Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its November 2025 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In November 2025 both the Total and Male rates dipped to 1.0% from 1.2% and 1.3% respectively, while the Female rate just turned up to 1.1% from 1.0%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In November 2025 the three Gonorrhea Urine, that were at 0.3% in the prior month, show the Total rate unchanged, the Male rate going up to 0.5%, and the Female rate down to 0.2%. In this month the three rates stayed around the linear trend.

Trichomonas Vaginalis Urine- Positivity Index



In November 2025 the all the Trichomonas Vaginalis Urine rates increased, Total rate to 0.4% from 0.2%, the Female rate to 0.7% from 0.4%, and the Male rate to 0.2% from 0.0%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In November 2025 all the Mycoplasma G. Urine rates decreased, the Female rate to 3.0% from 4.4%, the Total rate to 2.3% from 3.2%, and the Male rate to 1.8% from 2.1%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity, the positivity rates for the four tests below have December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In November 2025, the three Chlamydia Rectal rates show the Total rate going up to 2.2% from 1.7%, the Female rate also up to 2.9% from 1.9%, and the Male rate down to 1.4% from 1.6%. For Chlamydia Throat the 0.5% of the prior month for the three rates, has the Male rate down to 0.2%, the Total rate unchanged, and the Female rate up at 0.8%. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the volatility of the Gonorrhea Rectal lines is visible since April 2023, and in November 2025 the Female rate is turning up to 0.3% from 0.1%, the Male rate dropping to 0.7% from 1.6%, and the Total rate also going down to 0.5% from 0.9%. The Gonorrhea Throat rates have two moving up, the he Total rate to 1.0% from 0.7%, and the Female rate to 0.9% from 0.3%, and the Male rate unchanged at 1.1%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests.

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its October 2025 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In October 2025 the three rates remained unchanged, the Total rate at 1.2%, the Male rate at 1.3%, and the Female rate at 1.0%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In October 2025 the Gonorrhea Urine rates show all the rates at 0.3% although from different prior points, the Male rate unchanged, and the other two turning down, the Total rate from 0.5%, and the Female rate from 0.7%. In this month the three rates stayed around the linear trend.

Trichomonas Vaginalis Urine- Positivity Index



In October 2025 the Trichomonas Vaginalis Urine rates remained the same for the Total rate at 0.2% and the Female rate at 0.4%, while the Male rate decreased to 0.0%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In October 2025 for Mycoplasma G. Urine the Female rate went up to 4.4% from 4.0%, the Total rate unchanged at 3.2%, and the Male rate down to 2.1% from 2.4%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity, the positivity rates for the four tests below have December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In October 2025, the three Chlamydia Rectal rates turned up, the Total rate going to 1.7% from 1.2%, the Female rate to 1.9% from 1.3%, and the Male rate to 1.6% from 1.1%. For Chlamydia Throat, the three rates are at 0.5%, the Male rate up from 0.1%, the Total rate also up from 0.3%, and the Female rate the same as in September. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and in October 2025 have the Female rate decreasing further to 0.1% from 0.8%, the Male rate still increasing to 1.6% from 1.3%, and the Total rate dropping to 0.9% from 1.1%. The three Gonorrhea Throat rates moved in different directions, the Male rate up to 1.1% from 0.9%, the Total rate with no change at 0.7%, and the Female rate down to 0.3% from 0.5%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests. 


About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its September 2025 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In September 2025 the Total rate went up to 1.2% from 0.8%, the Male rate also up to 1.3% from 0.5%, and the Female rate decreased a bit to 1.0% from 1.1%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In September 2025 the Gonorrhea Urine rates all turned upward, the Total rate to 0.5% from 0.2%, the Female rate to 0.7% from 0.3%, and the Male rate to 0.3% from 0.2%. In this month the three rates stayed around the linear trend.

Trichomonas Vaginalis Urine- Positivity Index



In September 2025 the Trichomonas Vaginalis Urine rates decreased for the Total rate to 0.2% from 0.3% and the Female rate to 0.4% from 0.6%, while the Male rate is still unchanged at 0.1% for the last three months. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In September 2025 the three Mycoplasma G. Urine rates moved down, with the Female rate at 4.0% from 4.1%, the Total rate at 3.2% from 3.3%, and the Male rate at 2.4% from 2.6%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity, the positivity rates for the four tests below have December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In September 2025, the three Chlamydia Rectal rates turned down, Total rate going to 1.2% from 1.4%, the Female rate to 1.3% from 1.6%, and the Male rate to 1.1% from 1.2%. For Chlamydia Throat, the Male rate turned around to 0.1% from 0.4%, while the Female rate returned to 0.5% from 0.3%, and the Total rate remains at 0.3% since July 2025. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and in September 2025 have the Female rate decreasing to 0.8% from 1.0%, the Male rate increasing to 1.3 from 0.8%, and the Total rate higher at 1.1% from 0.9%. The three Gonorrhea Throat rates are now down, the Male rate at 0.9% from 1.3%, the Total rate at 0.7% from 1.2%, and the Female rate at 0.5% from 1.1%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests. 


About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its August 2025 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In August 2025 the three rates dipped from their July 1.4% point; the Total rate to 0.8%, the Male rate to 0.5%, and the Female rate to 1.1%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In August 2025 the Gonorrhea Urine rates show the Total rate down to 0.2% from 0.3%, the Female rate also down to 0.3% from 0.5%, and the Male rate just up to 0.2% from 0.1%. In this month the three rates stayed within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In August 2025 the Trichomonas Vaginalis Urine rates show the Total rate turning up to 0.3% from 0.1%, the Female rate also going up to 0.6% from 0.2%, while the Male rate is unchanged at 0.1%. The current rate levels are still within the general range of 0.0% to 1.5%

Mycoplasma Genitalium Urine - Positivity Index



In August 2025 the three Mycoplasma G. Urine rates moved from the 2.8% recorded in July, with the Female rate increasing to 4.1%, the Total rate also going up to 3.3%%, and the Male rate decreasing to 2.6%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity, the positivity rates for the four tests below have December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In August 2025, the Chlamydia Rectal rates show the Total rate going up to 1.4% from 1.1%, the Female rate also up to 1.6% from 0.9%, and the Male rate dropping to 1.2% from 1.4%. For Chlamydia Throat, the Male rate shows a rate of 0.4% after two months of 0.0%, while the Female rate turned down to 0.3% from 0.5%, and the Total rate remained the same at 0.3%. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and in August 2025 have the Female rate increasing to 1.0% from 0.4%, the Total rate also turning up to 0.9% from 0.7%, and the Male rate down to 0.8% from 1.1%. The three Gonorrhea Throat rates are up, the Male rate at 1.3% from 1.1%, the Total rate at 1.2% from 0.9%, and the Female rate at 1.1% from 0.8%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests. 

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its July 2025 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In July 2025 the three rates continue going upwards and all are at 1.4%; the Total rate from 1.2%, the Male rate from 1.3%, and the Female rate from 1.1%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In July 2025 the Gonorrhea Urine rates show the Total rate decreasing to 0.3% from 0.4%, the Female rate also down to 0.5% from 0.7%, and the Male rate unchanged at 0.1%. In this month the three rates stayed within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In July 2025 the Trichomonas Vaginalis Urine rates show the Total rate further decreasing to 0.1% from 0.3%, the Male rate also at 0.1% from 0.2%, and the Female rate dropping to 0.2% from 0.4%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In July 2025 the three Mycoplasma G. Urine rates are at 2.8%, with the Female rate decreasing from 3.3%, the Total rate also decreasing from 3.1%, and the Male rate unchanged.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity, the positivity rates for the four tests below have December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In July 2025, the Chlamydia Rectal rates show the Total rate still unchanged at 1.1%, the Female rate dropping to 0.9% from 1.2%, and the Male rate increasing to 1.4% from 1.0%. The Chlamydia Throat rates of 0.0% from last month now have the Male rate still without any positive results, the Female rate going to 0.5%, which turned the Total rate to 0.3%. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and in July 2025 have the Female rate down to 0.4% from 0.5%, the Total rate turning up to 0.7% from 0.4%, and the Male rate also upwards to 1.1% from 0.1%. The Gonorrhea Throat rates have the Male rate down to 1.1% from 1.2%, the Total rate unchanged at 0.9%, and the Female rate at 0.8% up from 0.7%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests. 

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its June 2025 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In June 2025 the three rates turned upwards, the Total rate to 1.2% from 1.0%, the Male rate to 1.3% from 1.0%, and the Female rate to 1.1% from 0.9%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In June 2025 the Gonorrhea Urine rates show the Total rate decreasing to 0.4% from 0.6%, the Male rate also down to 0.1% from 0.6%, and the Female rate increasing to 0.7% from 0.6%. In this month the three rates stayed within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In June 2025 the Trichomonas Vaginalis Urine rates show the Total rate falling a bit further to 0.3% from 0.4%, the Male rate just up to 0.2% from 0.1%, and the Female rate dropping to 0.4% from 0.7%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In June 2025 the Mycoplasma G. Urine rates show all the rates with downward direction, the Female rate to 3.3% from 4.3%, the Total rate to 3.1% from 3.7%, and the Male rate to 2.8% from 3.2%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity, the positivity rates for the four tests below have December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In June 2025, the Chlamydia Rectal rates show that only the Total rate remained at 1.1%, while the Female rate just went up to 1.2%, and
the Male rate down to 1.0%. The Chlamydia Throat rates all dropped to 0.0%, the Male rate from 0.4%, the Female rate from 0.8%, and the Total rate from 0.6%. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and in
June 2025 decreased further, the Female rate to 0.5% from 1.0%, the Total rate to 0.4% from 0.9%, and the Male rate to 0.1% from 0.9%. The Gonorrhea Throat rates have the Male rate returning to 1.2% from 0.8%, the Total rate again a tick lower to 0.9% from 1.0%, and the Female rate further down to 0.7% from 1.2%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests. 

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its April 2025 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In April 2025 the Total rate ticked up to 1.0% from 0.9%, the Male rate dropped to 0.9% from 1.1%, and the Female rate went up to 1.1% from 0.8%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In April 2025 the Gonorrhea Urine rates show the Total rate increasing to 0.6% from 0.4%, the Male rate down to 0.3% from 0.4%, and the Female rate up to 1.0% also from 0.4%. In this month the three rates remain within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In April 2025 the three Trichomonas Vaginalis Urine rates increased again, the Total rate to 0.5% from 0.3%, the Male rate to 0.3% from 0.2%, and the Female rate to 0.7% from 0.4%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In April 2025 the Mycoplasma G. Urine rates show the Female rate down to 3.5% from 4.0%, the Total rate unchanged at 3.6%, and the Male rate going up to 3.7% from 3.2%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity, the positivity rates for the four tests below have December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In April 2025, the Chlamydia Rectal rates show the Female rate unchanged at 2.0%, the Total rate down to 1.5% from 1.7%, and the Male
rate also down to 0.9% from 1.3%. The Chlamydia Throat rates show the Male rate still at 0.0%, the Female rate down to 0.5% from 0.7%, and the Total rate just a bit lower at 0.2% from 0.3%. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and in April 2025 show the three rates turning up, the Female rate to 1.1% from 0.4%, the Total rate to 1.2% from 0.6%, and the Male rate to 1.2% from 0.8%. The Gonorrhea Throat rates have the Male rate down at 1.2% from 1.4%, the Total rate going up to 1.4% from 1.2%, and the Female rate also up at 1.5% from 0.9%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests. 

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its March 2025 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In March 2025 the three rates turned down: the Total rate to 0.9% from 1.7%, the Male rate to 1.1% from 1.6%, and the Female rate to 0.8% from 1.7%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In March 2025 the Gonorrhea Urine rates show the three rates going up to 0.4%, the Total and Female from 0.2%, and the Male rate from 0.3%. In this month the three rates remain within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In March 2025 the three Trichomonas Vaginalis Urine rates increased, the Total rate to 0.3% from 0.2%, the Male rate to 0.2% from 0.1%, and the Female rate to 0.4% from 0.3%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In March 2025 the Mycoplasma G. Urine rates show the Female rate a tick down to 4.0% from 4.1%, the Total rate up to 3.6% from 3.3%, and the Male rate also up to 3.2% from 2.5%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity, the positivity rates for the four tests below have December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In March 2025, all the Chlamydia Rectal rates decreased, the Female rate to 2.0% from 2.8%, the Total rate to 1.7% from 2.3%, and the
Male rate to 1.3% from 1.7%. The Chlamydia Throat rates show the Male rate at 0.0% and the Female rate at 0.7%, both unchanged from the previous month, while the Total rate turned down to 0.3% from 0.4%. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and in March 2025 show the three rates decreasing, the Female rate to 0.4% from 0.6%, the Total rate to 0.6% from 1.1%, and the Male rate to 0.8% from 1.7%. The three Gonorrhea Throat rates decreased, the Male rate to 1.4% from 1.5%, the Total rate to 1.2% from 1.5%, and the Female rate to 0.9% from 1.4%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests. 


About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its February 2025 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In February 2025 the three rates increased: the Total rate to 1.7% from 0.9%, the Male rate to 1.6% from 1.0%, and the Female rate to 1.7% from 0.7%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In February 2025 the Gonorrhea Urine rates show the Total and Female rates going down to 0.2% from 0.3% and 0.5%, respectively, and the Male rate going up to 0.3% from 0.1%. In this month the three rates remain within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In February 2025 the three Trichomonas Vaginalis Urine rates have decreased, the Total rate to 0.2% from 0.4%, the Male rate to 0.1% from 0.2%, and the Female rate to 0.3% from 0.6%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In February 2025 the Mycoplasma G. Urine rates all turned downward; the Female rate to 4.1% from 5.3%, the Total rate to 3.3% from 4.5%, and the Male rate to 2.5% from 3.9%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity, the positivity rates for the four tests below have December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In February 2025, all the Chlamydia Rectal rates are up, the Female rate increasing to 2.8% from 1.9%, the Total rate to 2.3% from 1.8%, and the Male rate to 1.7% from 1.6%. The Chlamydia Throat rates show the Male rate at 0.0% from 0.3%, the Total rate at 0.4% from 0.2%, and the Female rate at 0.7% from 0.1%. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and in February 2025 show the three rates turning up, the Female rate to 0.6% from 0.5%, the Total rate to 1.1% from 0.5%, and the Male rate to 1.7% from 0.6%. The three Gonorrhea Throat rates increased again, the Male rate to 1.5% from 1.1%, the Total rate also to 1.5% from 1.0%, and the Female rate to 1.4% from 0.9%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests. 


About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its January 2025 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In January 2025 two of the rates decreased slightly, the Total rate to 0.9% from 1.0%, and the Male rate to 1.0% from 1.1%; while the Female rate at 0.7% is unchanged. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In January 2025 the Gonorrhea Urine rates broke from the uniformity of the prior two months; the Female rate turned up to 0.5% from 0.4%, while the Total and Male rates decreased from 0.4% to 0.3% and 0.1%, respectively. In this month the three rates remain within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In January 2025 the Total and Female rates stayed the same as the prior month at 0.4% and 0.6%, respectively, while the Male rate deceased to 0.1% from 0.3% . The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In January 2025 the Mycoplasma G. Urine rates all turned upward; the Female rate to 5.3% from 3.6%, the Total rate to 4.5% from 3.2%, and the Male rate to 3.9% from 2.8%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity, the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In January 2025, the Chlamydia Rectal rates show the Female rate increasing to 1.9% from 0.9%, the Total rate also going up to 1.8% from 1.4%, and the Male rate decreasing to 1.6% from 1.9%. The three Chlamydia Throat rates are lower; the Male rate at 0.3% from 0.5%, the Total rate at 0.2% from 0.6%, and the Female rate at 0.1% from 0.7%. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and in January 2025 show the Female rate going up to 0.5% from 0.3%, the Total rate down to 0.5% from 0.7%, and the Male rate also down to 0.6% from to 1.0%. The three Gonorrhea Throat rates have turned upwards, the Male rate to 1.1% from 1.0%, the Total rate to 1.0% from 0.8%, and the Female rate to 0.9% from 0.7%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests. 

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its December 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In December 2024 the three rates decreased; the Total rate to 1.0% from 1.3%, the Female rate to 0.7% from 1.4%, and the Male rate to 1.1% from 1.2%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In December 2024 the three Gonorrhea Urine rates moved down to 0.4% from 0.5%. In this month the three rates remain within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In December 2024 the Total rate stayed the same as the prior month at 0.4%, the Male rate increased to 0.3% from 0.1%, and the Female rate ticked down to 0.6% from 0.7%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In December 2024 the Mycoplasma G. Urine Total rate went up to 3.2% from 2.9%, the Male rate also up to 2.8% from 2.3%, while the Female rate stayed the same at 3.6%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In December 2024, the three Chlamydia Rectal rates turned downward, the Female rate to 0.9% from 2.4%, the Total rate to 1.4% from 2.4%, and the Male rate to 1.9% from 2.3%. The three Chlamydia Throat rates went up; the Male rate to 0.5% from 0.2%, the Total rate to 0.6% from 0.3%, and the Female rate to 0.7% from 0.5%. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and in December 2024 all have decreased; the Female rate to 0.3% from 0.7%, the Total rate to 0.7% from 1.2%, and the Male rate to 1.0% from 1.8%. The Gonorrhea Throat rates show the Male rate decreasing to 1.0% from 1.7%, the Total rate down to 0.8% from 1.2%, and the Female rate unchanged at 0.7%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests. 

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its November 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In November 2024 the three rates remain around or at 1.3%; the Total rate unchanged at 1.3%, the Female rate up to 1.4%, and the Male rate dropping to 1.2%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In November 2024 two of the Gonorrhea Urine rates continued to turn upward; the Total rate at 0.5% from 0.4%, and the Male rate also at 0.5% from 0.3%; while the Female rate remains unchanged at 0.5% for the third straight month. In this month the three rates remain within the trend.

Trichomonas Vaginalis Urine- Positivity Index



Mycoplasma Genitalium Urine - Positivity Index



Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In November 2024, the three Chlamydia Rectal rates rose again, the Female rate to 2.4% from 2.3%, the Total rate to 2.4% from 2.0%, and the Male rate to 2.3% from 1.7%. The three Chlamydia Throat rates are now lower; the Male rate at 0.2% from 0.7%, the Total rate at 0.3% from 0.7%, and the Female rate at 0.5% from 0.6%. Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and now show the Female rate going down to 0.7% from 0.8%, the Total rate up a notch again to 1.2% from 1.1%, and the Male rate increasing to 1.8% from 1.4%. The three Gonorrhea Throat rates decreased, with the Male rate at 1.7% from 2.4%, the Total rate at 1.2% from 1.8%, and the Female rate at 0.7% from 1.3%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests. 


About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its October 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In October 2024 the three rates went up to 1.3%; the Total rate from 0.9%, the Female rate from 1.0%, and the Male rate from 0.8%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In October 2024 two of the Gonorrhea Urine rates turned upward; the Total rate at 0.4% from 0.3%, and the Male rate at 0.3% from 0.2%; the Female rate remains unchanged from a month ago at 0.5%. In this month the three rates remain within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In October 2024 the Female rate is increasing to 0.7% from 0.5%, the Total rate decreasing to 0.3% from 0.5%, and the Male rate also going down to 0.0% from 0.5%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In October 2024 two Mycoplasma G. Urine rates have gone up to 3.3%, the Total rate from 2.8% , and the Male rate from 1.9%. Meanwhile, the Female rate dropped to 3.4% from 3.8%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In October 2024, the three Chlamydia Rectal rates have turned up, the Female rate at 2.3% from 1.7%, the Total rate at 2.0% from 1.3%, and the Male rate at 1.7 from 0.8%. The three Chlamydia Throat rates also increased, though continue to be aligned to their general trend with levels at or below 1.0%; the Male rate up to 0.7% from 0.3%, the Total rate to 0.7% from 0.2%, and the Female rate to 0.6% from 0.1%. Although within an overall smaller range of 0.0% to 3.5% when compared to the other swab rates, the Gonorrhea Rectal lines volatility, visible since April 2023, show the Female rate going up to 0.8% from 0.6%, the Total rate up a notch to 1.1% from 1.0%, and the Male rate unchanged from September at 1.4%. The three Gonorrhea Throat rates all increased, with the Male rate at 2.4% from 1.8%, the Total rate at 1.8% from 1.4%, and the Female rate at 1.3% from 1.0%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior that then other three swab tests, although the Chlamydia Throat swab rates are noticeably up for October.


About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its July 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In September 2024 the Total rate edged down to 0.9% from 1.0%, the Female rate also decreased to 1.0% from 1.4%, while the Male rate just ticked upward to 0.8% from 0.7%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In September 2024 the three Gonorrhea Urine rates turned upward; the Female rate to 0.5% from 0.3%, the Total rate at 0.3% from 0.2%, and the Male rate at 0.2% from 0.1%. In this month the three rates remain within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In September 2024 the three rates meet at 0.5%, with the Female rate dropping from 0.6%, the Total rate increasing from 0.4%, and the Male rate also going up from 0.2%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In September 2024 the three Mycoplasma G. Urine rates dropped; the Female rate to 3.8% from 5.1%, the Total rate to 2.8% from 4.3%, and the Male rate to 1.9% from 3.6%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In September 2024, the Chlamydia Rectal rates show the Total rate lower at 1.3% from 1.6%, the Male rate also down to 0.8% from 1.4%, and the Female rate unchanged at 1.7%. The Chlamydia Throat rates continue to be aligned to their general trend with levels at or below 1.0%, with the Male rate at 0.3% from 0.1%, the Total rate at 0.2% from 0.3%, and the Female rate down at 0.1% from 0.4%. Although within an overall smaller range of 0.0% to 3.5% when compared to the other swab rates, the Gonorrhea Rectal lines volatility, visible since April 2023, show the Female rate dropping to 0.6% from 0.9%, the Male rate turning up to 1.4% from 0.8%, and the Total rate ticking up to 1.0% from 0.9%. The three Gonorrhea Throat rates almost all flat, with the Male rate unchanged at 1.8%, the Female rate at 1.0% from 0.9%, and the Total rate at 1.4% from 1.3%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior that then other three swab tests.


About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its July 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In August 2024, all the rates changed direction to go up from their July levels; the Total rate to 1.0% from 0.8%, the Female rate to 1.4% from 1.0%, and the Male to 0.7% from 0.6%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In August 2024 the three Gonorrhea Urine rates dropped further; the Female rate down to 0.3% from 0.5%, the Total rate at 0.2% from 0.3%, and the Male rate at 0.1% from 0.2%. In this month the three rates remain within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In August 2024 the Female rate stayed at 0.6%, the Total rate increased to 0.4% from 0.3%, while the Male rate also went up to 0.2 from 0.1%. The current rate levels are still within the general range of 0.0% to 1.5%.%

Mycoplasma Genitalium Urine - Positivity Index



In August 2024 the Total Mycoplasma G. Urine rate dropped to 4.3% from 4.9%, the Male rate also decreased to 3.6% from 5.0%, and the Female rate went up to 5.1% from 4.9%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In August 2024, all the Chlamydia Rectal rates turned up, with the Total rate at 1.6% from 1.1%, the Female rate at 1.7% from 1.3%, and the Male rate at 1.4% from 0.9%. The Chlamydia Throat rates continue to be aligned to their general trend with levels at or below 1.0%, with the Male rate at 0.1% from 0.3%, the Total rate at 0.3% from 0.5%, and the Female rate also down at 0.4% from 0.7%. Although within an overall smaller range of 0.0% to 3.5% when compared to the other swab rates, the Gonorrhea Rectal lines volatility, visible since April 2023, has diminished; the Female rate going up to 0.9% from 0.8%, the Male rate decreasing to 0.8% from 1.1%, and the Total rate unchanged at 0.9%. The three Gonorrhea Throat rates turned around, with the Female rate going down to 0.9% from 2.0%, the Male rate at 1.8% from 1.9%, and the Total rate at 1.3% from 2.0%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior that then other three swab tests.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its July 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In July 2024, all the rates dropped from the June level of 1.4%, with the Total rate down to 0.8%, the Female rate to 1.0%, and the Male to 0.6%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In July 2024 the three Gonorrhea Urine rates are lower, the Female rate down to 0.5% from 1.2%, the Total rate at 0.3% from 0.7%, and the Male rate at 0.2% from 0.3%. In this month the three rates remain within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In July 2024 the Female rate turned down to 0.6% from 0.7%, the Total rate also decreased to 0.3% from 0.4%, while the Male rate is just up to 0.1% from 0.0%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In July 2024 the Total rate went up to 4.9% from 4.1%, the Male rate also increased to 5.0% from 2.6% , and the Female rate dropped to 4.9% from 5.4%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In July 2024, the Total Chlamydia Rectal rate shows a decrease to 1.1% from 1.3%, the Female rate also dropped to 1.3% from 1.8%, and the Male rate is up to 0.9% from 0.7%. The Chlamydia Throat rates continue to be aligned to their general trend with levels at or below 1.0%, with the Male rate at 0.3% from 0.2%, the Total rate at 0.5% from 0.3%, and the Female rate also up at 0.7% from 0.4%. Although within an overall smaller range of 0.0% to 3.5% when compared to the other swab rates, the Gonorrhea Rectal lines volatility, visible since April 2023, continues with the Total rate turning up to 0.9% from 0.7%, the Female
rate going down to 0.8% from 1.0%, and the Male rate increasing to 1.1% from 0.3%. The three Gonorrhea Throat rates have made a sharp upward turn with the Female rate going up to 2.0% from 0.8%, the Male rate up to 1.9% from 1.0%, and the Total rate up to to 2.0% from 0.9%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior that then other three swab tests.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its June 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In June 2024, all the rates converged at 1.4%, with the Total rate continuing to go up from 1.2% in May, the Female rate dropping from 1.5%, and the Male increasing from 0.9%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In June 2024, the Female rate is up again to 1.2% from 0.9%, the Total rate is also up to 0.7% from 0.5%, and the Male rate just turned upward to 0.3% from 0.2%. Looking at the trendline, this month's Female rate is moving over the trend while the other two remain within the trend.

Trichomonas Vaginalis Urine- Positivity Index



In June 2024 the Female rate turned up to 0.7% from 0.4%, the Total rate also went up to 0.4% from 0.3%, while the Male rate is at 0.0% from 0.2%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



In June 2024 two rates increased, the Total rate at 4.1% from 3.7% and the Female rate at 5.4% from 4.7%, while the Male rate just dropped to 2.6% from 2.7%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In June 2024, the three Chlamydia Rectal rates decreased, the Total to 1.3% from 1.8%, the Female rate to 1.8% from 2.0%, and the Male rate to 0.7% from 1.7%. The Chlamydia Throat rates continue to be aligned to their general trend with levels at or below 1.0%, with the Male rate at 0.2% from 0.3%, the Total rate unchanged at 0.3%, and the Female rate also flat at 0.4%. Although within an overall smaller range of 0.0% to 3.5% when compared to the other swabrates, the Gonorrhea Rectal lines volatility, visible since April 2023, continues with the Total rate dropping to 0.7% from 1.1%, the Female rate still going up to 1.0% from 0.6%, and the Male rate dropping to 0.3% from 1.7%. The three Gonorrhea Throat rates remain within the range of the prior seven months, and in this month the Female rate decreased to 0.8% from 1.3%, the Male rate up to 1.0% from 0.8%, and the Total rate down to 0.9% from 1.1%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs show a more volatile behavior that then other three swab tests.


About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Threads: @talenttesting

Miami, FL - June 10th, 2024 - Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its May 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In May 2024, as in the prior month, two rates continued going up, the Total to 1.2% from 1.0%, and the Female to 1.5% from 1.2%, while the Male rate is unchanged at 0.9%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



The downward direction of the previous three months has changed in May 2024; the Female rate up to 0.9% from 0.2%, the Total rate up to 0.5% from 0.2%, and the Male unchanged at 0.2%. Looking at the trendline, this month's rates can still be considered to be within regular level.

Trichomonas Vaginalis Urine- Positivity Index



In May 2024 the Female rate turned down to 0.4% from 0.8%, the Total rate also went down to 0.3% from 0.4%, while the Male rate increased to 0.2% from 0.1%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



Again as in the prior two months, the May 2024 rates show three different directions, the Total rate still dropping now at 3.7% from 4.7%, the Female rate going up to 4.7% from 4.6%, and the Male turning downward to 2.7% from 4.9%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In May 2024, the Chlamydia Rectal rates show the Total rate steady at 1.8% as in April, the Female rate decreasing to 2.0% from 2.4%, and the Male rate increasing to 1.7% from 1.2%. The Chlamydia Throat rates continue to be aligned to their general trend with levels at or below 1.0%, with the Male rate
at 0.3% from 0.1%, the Total rate also at 0.3% from 0.4%, and the Female rate at 0.4% from 0.6%. Although within an overall smaller range of 0.0% to 3.5% when compared to the other swab rates, the Gonorrhea Rectal lines volatility which is visible since April 2023 now shows all upward turns, with the Total rate increasing to 1.1% from 0.7%, the Female rate up to 0.6% from 0.4%, and the Male rate again increasing to 1.7% from 1.0%. The three Gonorrhea Throat rates remain within the
range of the prior six months and in this month the Female is just up to 1.3% from 1.2%, the Male down to 0.8% from 1.3%, and the Total rate just down to 1.1% from 1.2%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs show a more volatile behavior that then other three swab tests.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Miami, FL - Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its April 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In April 2024, all rates turned up; the Total is now 1.0% from 0.5%, the Male at 0.9% from 0.7%, and the Female at 1.2% from 0.2%. Seeing that historic levels have been around 2.0%, the curren rates being below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



For the third month in a row the rates in April 2024 kept their downward direction; the Female rate at 0.2% from 0.7%, the Male at 0.2% from 0.4%, and the Total rate at 0.2% from 0.5%. Looking at the trendline, this month's rates can still be considered to be within regular level.

Trichomonas Vaginalis Urine- Positivity Index



In April 2024 the Female rate went futher up to 0.8% from 0.5%, the Total rate remained unchanged at 0.4%, while the Male rate dropped to 0.1% from 0.3%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



As in the prior month, the April 2024 rates show three different directions, the Total rate still unchanged at 4.7%, the Female rate down at 4.6% from 5.6%, and the Male rate up to 4.9% from 3.7%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In April 2024, the Chlamydia Rectal rates show the Total rate climbing to 1.8% from 1.5%, the Female rate also up to 2.4% from 1.4%, and the Male rate decreasing to 1.2% from 1.7%. The Chlamydia Throat rates continue to be aligned to their general trend with levels at or below 1.0%, with the Male rate at 0.1% from 0.0%. Although within an overall smaller range of 0.0% to 3.5% when compared to the other swab rates, the Gonorrhea Rectal lines volatility visible since April 2023 seems less pronounced now, with the Total rate unchanged at 0.7%, the Female rate decreasing further to 0.4% from 0.7%, and the Male rate going up to 1.0% from 0.6%. The three Gonorrhea Throat rates remain within the range of the prior six months and in this month the Female is down to 1.2% from 1.6%, the Male up to 1.3% from 0.7%, and the Total rate unchanged at 1.2%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swab tests show a more volatile behavior that then other three swab tests.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Miami, FL - Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce a new partner site in Prague, Czech Republic.

The new partner site will offer the leading industry testing standard: Gold Standard Panel (GSP) and no additional draw or shipping fees. The office hours will be Monday to Friday from 8am to 12pm and results will be ready by next day.

So, whether it is Budapest or Prague TTS is proud to offer the Talent community options on where to get tested in Europe.

Talent Testing Prague:

CITYLAB s.r.o.
Address: Seifertova 89, Praha 3, 130 00 (2nd floor)
Phone number: +420 775 884 971 / europe@talenttestingservice.com

About Talent Testing Service (TTS)

As the industry leader in establishing testing standards, Talent Testing Service, Inc. (TTS) consistently provides talents with safe, courteous, affordable, and convenient testing options through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has been at the forefront of delivering the most advanced infectious molecular testing for the adult industry. Headquartered in Miami, Florida, TTS is a privately held company with subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV, Puerto Rico, and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Instagram: instagram/talenttesting
Threads: @talenttesting@threads.net

Miami, FL - April 8th, 2024 - Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its March 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In March 2024, for the second consecutive month, all rates dropped; the Total is now 0.5% from 0.9%, the Male at 0.7% from 1.1%, and the Female at 0.2% from 0.8%. Seeing that historic levels have been around 2.0%, the February 2024 rates below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



All the March 2024 rates turned downward; the Female rate at 0.7% from 1.0%, the Male at 0.4% from 0.5%, and the Total rate at 0.5% from 0.7%. Looking at the trendline, this month's rates can still be considered to be within regular level.

Trichomonas Vaginalis Urine- Positivity Index



In March 2024 the Female rate went up a step to 0.5% from 0.4%, the Total rate also up a bit to 0.4% from 0.3%, while the Male rate remains unchanged at 0.3%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



The March 2024 rates show three different directions, the Total rate unchanged at 4.7%, the Female rate up at 5.6% from 5.4%, and the Male rate down to 3.7% from 4.0%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In March 2024, the Chlamydia Rectal rates show the Total rate going up to 1.5% from 1.4%, the Male rate also increased to 1.7% from 1.5%, and the Female rate unchanged at 1.4%. The Chlamydia Throat rates continue to be aligned to their general trend with levels at or below 1.0%, note the Male rate is at 0%. Although within an overall smaller range of 0.0% to 3.5% when compared to the other swab rates, the Gonorrhea Rectal lines volatility since April 2023 is noticeable, with the Total rate now down to 0.7% from 1.2%, the Female rate decreasing to 0.7% from 1.7%, and the Male rate now steady at 0.6%. The three Gonorrhea Throat rates remain within the range of the prior six months and in this month all rates have a downward direction, the Female at 1.6% from 1.7%, the Male at 0.7% from 1.0%, and the Total at 1.2% from 1.4%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swab tests show a more volatile behavior that then other three swab tests.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its February 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In February all rates have turned down with respect to January; the Total is now 0.9% from 1.5%, the Male at 1.1% from 1.7%, and the Female at 0.8% from 1.4%. Seeing that historic levels have been around 2.0%, the February 2024 rates below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



In contrast to the prior month, all the February 2024 rates increased; the Female rate at 1.0% from 0.6%, the Male up to 0.5% from 0.2%, and the Total rate up to 0.7% from 0.4%. Looking at the trendline, this month's rates can still be considered to be within regular level.

Trichomonas Vaginalis Urine- Positivity Index



All the three rates for Febtuary 2024 dropped, the Female rate to 0.4% from 1.1%, the Total rate at 0.3% from 0.8%, and the Male rate to 0.3% from 0.5%. The current rate levels are still within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



The downward direction started in August 2023 has been resumed in February 2024. The Total rate decreased to 4.7% from 6.9%, the Female rate is at 5.4% from 7.6%, and the Male rate is at 4.0% from 6.0%. These rates continue to be monitored weekly.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In February 2024, the Chlamydia Rectal rates show a further drop in the Total rate going to 1.4% from 2.0%, the Male rate continued to decrease to 1.5% from 2.1%, and the Female rate now also dropping to 1.4% from 2.0%. The Chlamydia Throat rates continue to be aligned to their general trend with levels at or below 1.0%. Although within an overall smaller range of 0.0% to 3.5% when compared to the other swab rates, the Gonorrhea Rectal lines volatility since April 2023 continues, the Male rate now down to 0.6% from 2.1%, the Female rate increasing to 1.7% from 0.3%, and the Total rate now up at 1.2% from 1.0%. The three Gonorrhea Throat rates remain within the range of the prior five months but with levels continue to go in opposite directions for the Female and Male rates, the former up to 1.7% from 1.3%, and the latter down to 1.0% from 1.8%, and the Total rate decreasing to 1.4% from 1.5%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swab tests show a more volatile behavior that then other three swab tests.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Miami, FL - February 2nd, 2024 - Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its January 2024 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In January 2024 all rates have turned up with respect to December 2023; the Total is now 1.5% from 1.2%, the Male at 1.7% from 1.6%, and the Female at 1.4% from 0.7%. In summary, seeing that historic levels have been around 2.0%, the January 2024 rates below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



The January 2024 levels show decreases for the three rates; the Female rate at 0.6% from 0.8%, the Male down to 0.2% from 0.5%, and the Total rate dropping to 0.4% from 0.6%. Looking at the trendline, the January 2024 levels can still be considered to be within regular level.

Trichomonas Vaginalis Urine- Positivity Index



All the three rates for January 2024 are up, the Female rate to 1.1% from 0.1%, the Total rate at 0.8% from 0.1%, and the Male rate to 0.5% from 0.0%. The current rate levels are within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



The downward direction started in August 2023 has stopped, all the January 2024 rates have turned up. The Total rate increased to 6.9% from the December 2023 low of 6.1%, the Female rate is at 7.6% from 6.4%, and the Male rate is at 6.0 from 5.9%. These rates continue to be monitored weekly.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In January 2024, the Chlamydia Rectal rates show a further slight drop in the Total rate going to 2.0% from 2.1% , while the Male rate turned downward to 2.1% from 3.4%, and the Female rate now going up to 2.0% from 1.1%. The Chlamydia Throat rates continue to be aligned to their general trend with levels at or below 1.0%. Although within an overall smaller range of 0.0% to 3.5% when compared to the other swab rates, the Gonorrhea Rectal lines volatility since April 2023 continues, the Male rate now up to 2.1% from 1.0%, the Female rate decreasing to 0.3% from 1.3%, and the Total rate continuing to drop now at 1.0% from 1.2%. The three Gonorrhea Throat rates remain within the range of the prior four months but with levels again going in opposite directions for the Female and Male rates, the former down to 1.3% from 2.1%, and the latter up to 1.8% from 1.0%, and the Total rate decreasing to 1.5% from 1.6%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swab tests show a more volatile behavior that then other three swab tests.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.


https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its December 2023 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the November 2022 peak. In December 2023 the Male rate of 1.6% is the same as in the prior month. The Female rate dropped further from 1.3% to 0.7%, while the Total also decreased from 1.5% to 1.2%. In summary, seeing that historic levels have been around 2.0%, the December 2023 rates below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



The December 2023 levels show the Female rate turning up to 0.8% from 0.2% in November, the Male rate just ticking up to 0.5% from 0.4%, and the Total rate also rising to 0.6% from 0.3%. Looking at the trendline, the December 2023 levels can still be considered to be within anticipated levels.

Trichomonas Vaginalis Urine- Positivity Index



All the three indicators for December 2023 dropped, the Female rate to 0.1% from 0.6%, the Total rate also at 0.1% from 0.4%, and the Male rate to 0.0% from 0.2%. The current rate levels are within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



The drop on the three rates continued in December 2023. The Total population rate dropped to its lowest level at 6.1% from 8.1% in November, continuing the downward direction from the prior four months. In a similar manner, the Male rate hit a low at 5.9% from 7.1%, it is a fifth consecutive monthly drop. The Female rate now shows four downward months with a low at 6.4% from 9.1%. These rates continue to be monitored weekly.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In December 2023, the Chlamydia Rectal rates show a slight drop in the Total rate going to 2.1% from 2.3%, the Male rate increasing for second consecutive month to 3.4% from 2.5%, and the Female rate drop continuing to 1.1% from 2.2%. The Chlamydia Throat rates continue to be aligned to their general trend with levels below 0.5%. Although within an overall smaller range of 0.0% to 3.5%, the Gonorrhea Rectal lines volatility since April 2023 continues, the Male rate down to 1.0% from 2.3%, the Female rate increasing to 1.3 from 0.7%, and the Total rate down to 1.2% from 1.5%. The three Gonorrhea Throat rates remain within the range of the prior three months but with inverted levels for the Female and Male, the former now at 2.1% from 0.9%, and the latter down to 1.0% from 2.0%, and the Total rate increasing to 1.6% from 1.4%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swab tests show a more volatile behavior that then other three swab tests.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Ft. Lauderdale (954) 799-8840 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Miami, FL – December 7th, 2023 - Talent Testing Service (TTS) is excited to announce a new wholly owned location where the action is at: Fort Lauderdale, FL.

The new location will offer the leading industry testing standard: Gold Standard Panel (GSP) at no additional draw or shipping fees. The office hours will be Monday to Friday from 8am to 4pm and results will be posted that same night.

So, whether it is Miami, Orlando, Tampa and now Fort Lauderdale TTS is proud to offer the Talent community more options on where to get tested.

Talent Testing Service - Fort Lauderdale
5253 NW 33rd Ave
Ft Lauderdale, FL 33309
954-406-8840


About Talent Testing Service (TTS)
As the industry leader in establishing testing standards, Talent Testing Service, Inc. (TTS) consistently provides talents with safe, courteous, affordable, and convenient testing options through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has been at the forefront of delivering the most advanced infectious molecular testing for the adult industry. Headquartered in Miami, Florida, TTS is a privately held company with subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV, Puerto Rico, and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885 0812 / Fort Lauderdale (954) 406-8840 /
Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Puerto Rico (787) 275-1919

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Instagram: instagram/talenttesting
Threads: @talenttesting@threads.net

Miami, FL - December 4th, 2023 - Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its November 2023 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from November 2022 peak. In November 2023 the Male rate dropped to 1.6% from 1.8% in the prior month. The Female rate has also dropped from 1.4% to 1.3% while the Total rate decreased from 1.6% to 1.5%. In summary, seeing that historic levels have been around 2.0%, the current November rates below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



The November levels show Female rate dropping to 0.2% from 0.5% in October, the Male rate remains unchanged at 0.4%, and the Total rate dropping to 0.3% from 0.4%. Looking at the trendline, the November rates can still be considered to be within regular behavior.

Trichomonas Vaginalis Urine- Positivity Index



All the three indicators for October were at 0.5% and show in November an increase in the Female rate to 0.6%, a decrease in the Male rate to 0.2%, and the Total rate going down to 0.4%. The current rate levels are within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index



The three rates continue to drop, the Total population rate dropped to its lowest level at 8.1% from 10.1% in October, continuing the downward direction from the prior four months. In a similar manner, the Male rate decreasing to 7.1% from 9.0% is a fourth consecutive monthly drop. The Female rate now shows three downward months with a 9.1% from 11.1%. These rates continue to be monitored weekly.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In November, the Chlamydia Rectal rates show a slight uptick in the Total rate going to 2.3% from 2.2%, the Male rate increasing to 2.5% from 1.6%, and the Female rate dropping to 2.2% form 2.7%. The Chlamydia Throat rates continue to be aligned to their general trend with levels close to a range between 0.5% and 1.0%. A different situation is seen in the Gonorrhea Rectal lines, the Male rate now going up to 2.3% from 1.6%, the Female rate decreasing to 0.7% from 1.3%, and the Total rate up to 1.5% from 1.4%. The three Gonorrhea Throat rates have turned downward, with the Male rate at 2.0% from 2.3%, the Female rate at 0.9% from 1.3%, and the Total rate decreasing to 1.4% from 1.7%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swab tests show a more volatile behavior that then other three swab tests.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812 Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its October 2023 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the peak in November 2022. In October the Male rate has dropped to 1.8% from 2.0% in the prior month. The Female rate has remained steady at 1.4% while the Total rate decreased from 1.7% in September to 1.6%. In summary, seeing that historic levels have been around 2.0%, the current October rates at or below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



The October levels show minimum variation, with the Female rate dropping to 0.5% from 0.6% in September, the Male rate going up to 0.4% from 0.3%, and the Total rate unchanged at 0.4%. Looking at the trendline, the October rates can still be considered to be within regular behavior.

Trichomonas Vaginalis Urine- Positivity Index



The three indicators for October went up and hit the same rate of 0.5%, with the Male rate going up from 0.1% in September, and both the Female and Total rates going up from 0.2%. The current rate levels are within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index

THESE RATES ARE BEING MONITORED WEEKLY GIVEN THEIR HIGH LEVELS



October as in September shows decreases in the three rates, where the Total population rate dropped to its lowest level at 10.1% from 17.0% in September, continuing the downward direction from the prior three months. In a similar manner, the Male rate decreasing to 9.0% from 12.5% is a third consecutive monthly drop. The Female rate now shows two downward months with an 11.1% from a 20.9%. These rates continue to be monitored weekly.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In October, the three Chlamydia Rectal rates decreased, the Total rate going to 2.2% from 2.5%, the Female rate at 2.7% from 2.8%, and the Male rate at 1.6% from 2.1%. The Chlamydia Throat rates continue to be aligned to their general trend with levels close to a range between 0.5% and 1.0%. A different situation is seen in the Gonorrhea Rectal lines, the Male rate down to 1.6% from 2.1%, the Female rate increasing to 1.3% from 0.2%, and the Total rate up to 1.4% from at 1.1%. The three Gonorrhea Throat rates have taken an upward direction, with the Male rate up again to 2.3% from 2.0%, the Female rate at 1.3% from 0.6%, and the Total rate increasing to 1.7% from 1.2%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swab tests show a more volatile behavior that then other three swab tests.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

Miami, FL - October 4th, 2023 - Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its September 2023 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

PLEASE NOTE THAT THE DATA IS NOW PRESENTED IN THREE GROUPS: FEMALE, MALE AND TOTAL.

Chlamydia Urine - Positivity Index



Overall, the three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the peak in November 2022. However, in September there is a jump in the Male rate to 2.0% from 1.2% in August, which has pulled the Total rate to 1.7% from 1.3%. The Female rate is a bit lower in September at 1.4% from 1.5% in August. In summary, seeing that historic levels have been around 2.0%, the current September rates at or below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



The Female rate in September has dropped to 0.6% from 0.8% in August, while the Male rate has remained steady at 0.3%, and the Total rate decreased to 0.4% from 0.5%. Looking at the trendline, the September rates can still be considered to be within regular behavior.

Trichomonas Vaginalis Urine- Positivity Index



The Total positivity rate of September has edged down to 0.2% from 0.3% in August as a consequence of the Male rate decreasing to 0.1% from 0.5%, although the Female rate turned up to 0.2% from 0.1%. The current rate levels are within the general range of 0.0% to 1.5%.1.5%.

Mycoplasma Genitalium Urine - Positivity Index

THESE RATES ARE BEING MONITORED WEEKLY GIVEN THEIR HIGH LEVELS



September is the first month when the three rates have decreased, seeing that the Total population rate dropped to 17.0% from 21.7% in August, continuing the downward direction from the last two months. The similar continuation in pattern is shown in the Male rate going down to 12.5% from 15.9%. The Female rate changed direction again and decreased to 20.9% from the prior high of 26.8% in August. These rates continue to be monitored weekly given their high levels.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In September the Chlamydia Rectal rates show a slight upward turn with the Total rate going up to 2.5% from 1.5%, the Female rate up to 2.8% from 1.3%, and the Male rate at 2.1% from 1.8%. The Chlamydia Throat rates continue to be aligned to their general trend with levels close to 0.5%. The three Gonorrhea Throat rates have distinct levels with the Male rate jumping to 2.1% from 1.1%, the Female rate dropping to 0.2% from 1.3%, while the Total rate staying almost unchanged at 1.1% from 1.2%. Similarly, the Gonorrhea Rectal lines show the Male rate up to 2.0% from 1.0%, the Female rate decreasing to 0.6% from 1.2%, and the Total rate at 1.2% from 1.1%. In conclusion, the rate levels displayed in three of the four swab tests are somewhat breaking from their regular levels, with only the Chlamydia Throat staying along its general trend..

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812
Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Miami, FL - September 25, 2023 - Starting on September 25, 2023, Talents testing positive for Mgen (Mycoplasma genitalium), Trich (Trichomoniasis), Chlamydia, and/or Gonorrhea will be able to have free retests eight days after their Gold Standard Panel positive result. Talents can continue to retest for up to 30 days after their first positive result.

To schedule a free retest, Talents need to contact Talent Testing Service (TTS).

This initiative underscores TTS’s continued commitment to ensuring the health and safety of Talents and the industry.

About Talent Testing Service (TTS)

As the industry leader in establishing testing standards, Talent Testing Service, Inc. (TTS) consistently provides talents with safe, courteous, affordable, and convenient testing options through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has been at the forefront of delivering the most advanced infectious molecular testing for the adult industry. Headquartered in Miami, Florida, TTS is a privately held company with subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV, Puerto Rico, and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) 305.792.2090 / Los Angeles 818.885.0812 / Las Vegas 702.868.8900 / Orlando 407.768.4215 / Tampa 813.822.0077 / Puerto Rico 787.275.1919 / Budapest
+36 70.904.9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Instagram: instagram/talenttesting
Threads: @talenttesting@threads.net

Miami, FL - September 5th, - Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its August 2023 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

PLEASE NOTE THAT THE DATA IS NOW PRESENTED IN THREE GROUPS: FEMALE, MALE AND TOTAL.

Chlamydia Urine - Positivity Index



The three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the peak in November 2022. The uptick seen in July for Total and Female has been reversed in August with rates going down to 1.3% and 1.5% from 1.8% and 1.9% respectively. The Male rate is a bit lower in August at 1.2% from 1.7% in July. In summary, seeing that historic levels have been around 2.0%, the current August rates below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



The rates in August show opposite turns with respect to July, with Female going up to 0.8% from 0.5%, Male going down to 0.3% from 0.8% and the Total rate decreasing to 0.5% from 0.7%. Looking at the trendline, as in July, the August rates can still be considered to be within regular behavior.

Trichomonas Vaginalis Urine- Positivity Index



The Trichomonas Vaginalis Total positivity rate turned is further down to 0.3% in August from the 0.6% in July, with the Female rate also going down to 0.1% from 1.1% while the Male rate turn upward to 0.5%. The current rate levels are well within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index

THESE RATES ARE BEING MONITORED WEEKLY GIVEN THEIR HIGH LEVELS



The Total population rate of 21.7% in August has broken the steady upward path seen in the previous four months. The similar break in pattern is shown in the Male rate going down to 15.9% which is a significant drop from the peak in July at 32.7%. The Female rate changed course and hit a new high at 26.8%. These rates continue to be monitored weekly given their high levels.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start to trend downward. In this regard, all the levels recorded for Chlamydia Rectal and Throat Swabs are aligned to their general trend, with rates close to 1.5% for Chlamydia Rectal and 0.3% for Chlamydia Throat. The three Gonorrhea Throat rates are clustered at around 1.1% in August, which shows the Total rate on steady trend while the Female and Male coming from different directions. The Gonorrhea Rectal lines show a marked turn upward from a month ago, with the Female rate reaching a peak of 1.3%, and the Total and Male rates close behind at 1.2% and 1.1%. In conclusion, the rate levels displayed in three of the four swab tests would be considered to be at regular levels, with the Gonorrhea Rectal outside that general trend.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812
Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Puerto Rico (787) 275-1919 / Budapest +36 70 904 9005

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Miami, FL - Aug 14, 2023 – On August 10th, 2023 Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, released their monthly Sexually Transmitted Infection statistics, including data for *Mycoplasma Genitalium (Mgen), which TTS started offering as a standalone test in April.

The four-month data for Mgen shows an upward trend for the total population, reaching a positivity rate of 23.4% in July. This incline is being driven by the Male positivity rate which peaked at 32.7%. The Female rate declined to 14.5% in July but is still significant.

Given the limited sample size for the Mgen analysis, TTS will continue to monitor closely the positivity rates within the Talent community. In response to this trend, TTS will now offer FREE Mgen testing to those who request it as part of their routine test panel.

TTS has also taken the initiative to engage with various industry stakeholders, sharing the comprehensive Mgen testing analysis, further demonstrating TTS's dedication to industry collaboration and responsible data sharing. “TTS is glad to see the industry stakeholders joining our April 2023 decision to offer Mgen testing. We are taking it now a bit further and offering it for free” said Sixto Pacheco President and CEO of Talent Testing Service, Inc.

TTS remains resolute in its mission to prioritize the health and well-being of talents by providing reliable testing services and facilitating open conversations around sexually transmitted infections. As the industry leader, TTS continues to set the bar higher for health standards and responsible practices.


About Talent Testing Service (TTS)

As the industry leader in establishing testing standards, Talent Testing Service, Inc. (TTS) consistently provides talents with safe, courteous, affordable, and convenient testing options through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has been at the forefront of delivering the most advanced infectious molecular testing for the adult industry. Headquartered in Miami, Florida, TTS is a privately held company with subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV, Puerto Rico, and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812
Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Puerto Rico (787) 275-1919

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice
Instagram: instagram/talenttesting
Threads: @talenttesting@threads.net

*For more information about Mycoplasma Genitalium please visit:

https://www.talenttestingservice.com/faq.asp
https://www.cdc.gov/std/mgen/stdfact-Mgen-detailed.htm

Miami, FL - August 10th, 2023 - Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its June and July 2023 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

PLEASE NOTE THAT THE DATA IS NOW PRESENTED IN THREE GROUPS: FEMALE, MALE AND TOTAL.

Chlamydia Urine - Positivity Index



The three Chlamydia Urine rates show a similar behavior through time including the steady downward trend from the peak in November 2022, although the July 2023 levels for General and Female have turned upwards to 1.8% and 1.9% respectively. The Male rate is at 1.7% now. In summary, seeing that historic levels have been around 2.0%, the current July rates below 2.0% can be considered to be within expectations.

GC (Gonorrhea) Urine - Positivity Index



The Female and Male Gonorrhea Urine rates hit opposite levels in July 2023, with 0.5% and 0.8% respectively, while the total rate has turned upwards reaching a rate of 0.8%. Looking at the trendline, the July rates can be considered to be within regular behavior.

Trichomonas Vaginalis Urine- Positivity Index



The Trichomonas Vaginalis Total positivity rate turned downward to 0.6%, with the Female rate going also down to 1.1% while the Male rate is still close to zero. The separation recorded in the last two months amongst the three groups reflects most of the historical behavior, where the Female level is always above the Male. Furthermore, the current rate levels are within the general range of 0.0% to 1.5%.

Mycoplasma Genitalium Urine - Positivity Index

THESE RATES ARE BEING MONITORED WEEKLY GIVEN THEIR HIGH LEVELS



The four month data shows an upward trend for the Total population with a July reading of 23.4% which is being driven by the Male rates which now also reached a peak at 32.7%. The Female rate has turned downward to 14.5% in July.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index



Based on market activity the positivity rates for the four tests below has December 2022 as a relevant, starting point where all levels display their peak and then start to trend downward. It is in this way that the Gonorrhea Rectal lines show a downward turn from a month ago, with the Female rate now at 0%. On a different trajectory the Male Gonorrhea Throat rate has gone up to 2.2% while the Female rate dropped to 0.6%. In conclusion, the positive rates displayed in three of the four swab tests would be considered to be at regular levels, with the Gonorrhea Throat being the one outside the general trend.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812
Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Puerto Rico (787) 275-1919
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service (TTS), the leading industry testing provider committed to ensuring the well-being of talents, is pleased to announce the release of its May 2023 update featuring the latest positivity rates of Sexually Transmitted Diseases (STDs).

Chlamydia Urine - Positivity Index



The Chlamydia Urine positivity rate of 1.7% for May 2023 is the same as the prior month which does not affect the trendline seen last month.

GC (Gonorrhea) Urine - Positivity Index



The Gonorrhea Urine rate of 0.6% for May 2023 is the same as in April, keeping the trendline going in the same direction.

Trichomonas Vaginalis Urine- Positivity Index



The Trichomonas Vaginalis positivity rate continues to show a downward trendline in the range of 0.5% to about 1.0%. The May 2023 rate is 0.3% while the April rate was 0.4%.

Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs – Positivity Index



Based on market activity, the positivity rates for the four tests have Dec 2022 as a relevant starting point where all levels display their peak and then start to trend downward. The curve for Chlamydia Rectal Swab does show a turn upward with a May 2023 rate of 3.3% from 1.7% the prior month. Please note that the positivity range for each test is unique.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885 0812
Las Vegas (702) 868-8900 / Orlando (407) 768-4215 / Tampa (813) 822-0077 / Puerto Rico (787) 275-1919
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Services (TTS), the industry testing leader in safeguarding the well-being of talents, is pleased to announce a groundbreaking initiative aimed at fortifying talent safety and promoting overall industry health. In line with our unwavering commitment to excellence, TTS will now provide monthly updates in the form of statistical graphs, showcasing the positivity rates of the Sexually Transmitted Diseases (STDs) that we rigorously test for.

TTS firmly believes that knowledge is power, and by sharing these crucial insights, we foster a collective commitment to the highest standards of safety within the industry. The monthly statistical graphs will serve as a powerful tool, shedding light on historical positivity rates, thus empowering individuals to prioritize their health and minimize potential risks.

With this pioneering initiative, Talent Testing Services (TTS) reaffirms its position as an industry trailblazer, continuously striving to advance talent well-being and shape the future of the entertainment industry. By combining cutting-edge technology, unparalleled expertise, and a resolute commitment to safety, TTS remains the premier testing resource for Talents in the industry.

Chlamydia Urine - Positivity Index

The Chlamydia Urine positivity rate of 1.7% for Apr 2023 shows a level within the range of 1 to 2.0% that was quite steadily observed from Jan to Oct 2022. In addition, if this 1.7% is placed next to Oct 2022 it would continue the downward trendline for the 36 months from Nov 2019 to Oct 2022. Moreover, although the spike from Nov 2022 to Jan 2023 has changed the trendline's direction upward, seeing rates inside the 1 to 2.0% will be the expectation to track as 2023 develops.



GC (Gonorrhea) Urine - Positivity Index

The Gonorrhea Urine rate of 0.6% for Apr 2023 is one of the lowest levels recorded in the 42 month period from Nov 2019, where the downward trendline has been in a
range around 1.4 to 0.9%.



Trichomonas Vaginalis Urine- Positivity Index

The Trichomonas Vaginalis positivity rate shows a 42 month downward trendline in the rage of 0.5% to about 1.0%. The Apr 2023 rate of 0.4% continues along the
same direction.



Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs - Positivity Index

Based on market activity the positivity rates for the four tests below has Dec 2022 as a relevant, starting point where all levels display their peak and then start to trend downward. Please note that the positivity range for each test is unique.



About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Tampa, FL, Orlando, FL, Las Vegas, NV Puerto Rico and Budapest, Hungary.

https://www.talenttestingservice.com
info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792-2090
Los Angeles (818) 885 0812
Las Vegas (702) 868-8900
Orlando (407) 768-4215
Tampa (813) 822-0077
Puerto Rico (787) 275-1919

Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service (TTS) has been at the forefront in providing best-in-class testing services since 2005 to achieve one primary mission - the safety of the Adult Performers.

In conversations with production companies, agents, and other industry stakeholders TTS has taken the initiative to extend the opening hours of its Northridge office to accommodate the rigorous COVID-19 testing schedule.

The new expanded hours of operation are:

- Monday thru Friday

06:00 AM - 08:30 AM PST
Only COVID-19 testing will be performed during these hours.
Blood work may be performed at this time frame depending on the scheduled workload.
By Appointment only
All Talent and Crew must have their tests already paid online through the website.
All appointments must have been made by 04:00 PM PST of the previous day for scheduling purposes.
After 08:30 AM PST the regular workday will commence.

- Saturday Schedule

09:30 AM - 12:30 PM PST
Blood and COVID-19 testing will be performed during these hours.
By Appointment only
All Talent and Crew must have their tests already paid online through the website.
All appointments must have been made by 04:00 PM PST on Friday for scheduling purposes.

- Sunday Schedule

09:30 AM - 12:30 PM PST
Only COVID-19 testing will be performed during these hours.
By Appointment only
All Talent and Crew must have their tests already paid online through the website.
All appointments must have been made by 04:00 PM PST on Friday for scheduling purposes.

About Talent Testing Service, Inc. (TTS)
As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable, and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Oakland, CA and Las Vegas, NV.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Las Vegas (702) 868-8900 / Oakland (510) 346-5538
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service (TTS) has implemented a “Sign and Scan” feature for all Talents who visit their Associated Draw Facilities (ADF) across the United States, Puerto Rico and Canada. With a simple scan of the QR code, using a smart phone camera or applicable QR Code app, the Talent automatically advises TTS that they have been to the specific ADF, that their samples have been collected, and automatically advises FedEx for a pickup.

This QR Code is found next to the signature line on page 3 of the paperwork sent to the ADF. Once the ADF has completed the paperwork, all the Talent has to do is Sign and Scan!

“A common issue has always been the “blind spot” problem: TTS not knowing when a talent visited an ADF facility up to the point where the sample has been picked up by the Courier service. By simply scanning the QR code, TTS will have a better insight into tracking of the inbound shipment of samples originating at its Associated Drawing Facilities (ADF)”, said Sixto Pacheco, President and CEO of Talent Testing Service. “The addition of this tracking feature to our toolbox will help the TTS team in identifying and resolving shipping problems at an earlier stage”, Pacheco continued.

About Talent Testing Service, Inc. (TTS)
As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Oakland, CA and Las Vegas, NV.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Las Vegas (702) 868-8900 / Oakland (510) 346-5538
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service (TTS) has been at the forefront in providing best-in-class testing services since 2005 in order to achieve one primary mission – the safety of the Adult Performers. Since the AVN Awards held in January of 2019, TTS representatives have been traveling to Europe meeting with counterparts, colleagues and various industry leaders in order to achieve several goals. These include:

• Providing clearance status through the TTS online portal system
• Pairing current testing protocols and clearance algorithms
• Offering performers the most accurate and best possible testing services available at a fair and competitive price
• Providing the adult community with opportune and effective flow of information when health emergencies occur

“We are proud to say that these meetings have been very successful. The HIV-1 PCR test has been implemented and is being performed every 14 days” said Sixto Pacheco, President & CEO of TTS. “We are slowly and cautiously, through a phased approach, pairing the systems. Our ultimate goal is to have all talent feel comfortable that when tested, they receive the best in class testing services and more importantly – the talents health is protected”.

TTS expects that once the full implementation is completed, the TTS clearances will apply to all talent served on both sides of the Atlantic. Full implementation is expected to be completed by the third quarter of 2019.

About Talent Testing Service, Inc. (TTS)
As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Oakland, CA and Las Vegas, NV.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Las Vegas (702) 868-8900 / Oakland (510) 346-5538
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

In early February, TTS listened to the concerns of the industry and added the 4th generation HIV Ag/Ab assay to the Gold Standard Panel as a standard test. The inclusion of this test into the GS Panel prompted a host of internal changes at TTS. These changes included, but were not limited to, re-addressing testing algorithms, new clearance / non-clearance limitations and a revamping of the Medical Health Questionnaire (MHQ).

"As a facility that caters to the specific needs of the Adult Industry, our MHQ helps us determine what specific health problems our program participants may be exposed and are at increased risk to" said Sixto Pacheco, President & CEO of TTS. "For close to 15 years, TTS has always complied with, federal, state and local laws and regulations, including but not limited to HIPAA regulations. We have never sold, rented, leased or given away any information regarding any of our patients, Talents and/or Donor/Participants (D/Ps) - and never will." Pacheco continued.

Pacheco added that "We will again revise the MHQ and starting on Monday April1st, Talents can re-do their MHQ and select "Decline to Answer" for those questions they feel uncomfortable answering or deem inappropriate".

About Talent Testing Service, Inc. (TTS)
As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Oakland, CA and Las
Vegas, NV.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812 Las Vegas (702) 868-8900 / Oakland (510) 346-5538

As a primary stakeholder in the protection of the health of Adult Performers in the Industry, Talent Testing Service (TTS) has been at the forefront in providing best-in-class testing services since 2005. We have been able to provide these services primarily due to the fact of being highly involved in the developmental process of the ever evolving science of infectious disease testing with our diagnostic and molecular testing partners.

At this moment our data disputes the recent statements circulating, in the Adult Industry, regarding "Undetectable=Untransmittable" since this cannot be proven at a 100% accuracy. We would rephrase this as "Undetectable = Extremely Low Probability of Transmission". Due to this extremely low probability of transmission, however minute, it is still a risk and we should all err on the side of caution.

Our Quality Assurance (QA) program mandates that we randomly verify through different peer programs the accuracy and specificity of the assays to make sure they are working as expected. In addition to this, our QA program also takes into consideration external factors that may affect the veracity and integrity of the testing program we have in place. As a whole, the QA program is an ever evolving process striving to achieve one goal - the safety of Adult Performers.

After listening to the Industry's concerns, "Talent Testing Services will not only continue to participate in the peer program described above, but the Gold Standard Panel (GSP) will be enhanced to include the Genetic Systems HIV-1/HIV-2 Plus O EIA. This is an FDA cleared test to detect antibodies against HIV-1, HIV-2 and Group O. This test is being added to the GSP at no additional cost," said Mr. Sixto Pacheco, President and CEO of Talent Testing Service.

"These changes come after consultations with Talents, Agents and Production companies throughout the industry" said Sixto Pacheco, President & CEO of TTS. "TTS prides itself on being at the forefront of industry leading testing protocols. The new GSP test is in line with our commitment to continuously improve the available safeguards directed at the health of the Talent and the industry as a whole" Pacheco continued.
At this moment we recommend that the Free Speech Coalition direct their Licensed Healthcare Providers to implement the same immediately.

About Talent Testing Service, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2005, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Oakland, CA and Las Vegas, NV.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Las Vegas (702) 868-8900 / Oakland (510) 346-5538
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

As part of our continued effort to always be improving our services to our clients, and with input from our new Medical Director, Dr. Jason Dazely, Talent Testing Services is introducing a new and improved Medical History Questionnaire (MHQ). This MHQ has been revamped from our previous version and is necessary that all Talents answer it before their next test. The MHQ will then need to be revised every two (2) years.

This MHQ is private and will only be viewed by trained medical staff at TTS.

In order to complete the same, please call Jennifer, Maria or your favorite TTS agent who will gladly help in completing the same. You may also complete the same online by:

Logging into your TTS dashboard at: https://www.talenttestingservice.com
Click the link that states "Please complete MHQ to Get Tested"

What is an MHQ?
TTS has tailored its MHQ specifically for the Adult Industry clientele. Our MHQ captures practical, reliable and valid information from the Talent's point of view. The answers will help our Medical Staff better address a Talent's health concerns, based on their MHQ.

About Talent Testing Services, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Oakland, CA and Las Vegas, NV.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Las Vegas (702) 868-8900 / Oakland (510) 346-5538
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Take Advantage of a Promotional Discount as Part of the Opening Celebrations!

January 10th, 2017

Talent Testing Service, Inc. (TTS) is proud to announce the opening of its West Coast Laboratory Operations in Las Vegas, Nevada. In partnership with BioCollections Worldwide, Inc. (BCW), TTS will be able to provide earlier than ever test results for customers who get their blood drawn at the Northridge and Las Vegas locations.

"Reporting will be considerably faster than what our Miami Lab was reporting, so all LA and Vegas customers will be pleased. In fact, this is in response to all of our Talent customers who were asking for earlier results for the West Coast. We are proud to say, we've listened and delivered" said Sixto Pacheco, President of Talent Testing Service.

As a special kick off promotion for the new lab in Las Vegas, TTS is offering a 20% discount on its Gold Standard Panel Package nationwide from January 11th, 2017 through January 21st, 2017.

Customers who enter the Coupon Code "VegasTTS2017" will receive an instant 20% Discount off the Gold Standard Panel.

For any questions regarding this offer and/or questions about our West Coast Operations, please contact us at 818-885-0812 or 305-792-2090.

About Talent Testing Services, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA, Oakland, CA and Las Vegas, NV.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Las Vegas (702) 868-8900 / Oakland (510) 346-5538
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

May 27th, 2015

After serious feedback from Talents, Agents and Producers, Talent Testing Service, Inc. (TTS) is proud to announce its new redesign website. The new seamless look for PC's, iOS and Android devices offers:

"FBuddy" Feature

This is the "I'm ok to shoot screen!" If you have a mobile device you can access the FBuddy feature immediately and show your partners/co workers your "Cleared Status".

This is how it works: When you log in, you will be asked to be logged in to the FBuddy on the specific device, every time you go to the site. The next time you log into that device it will take you directly to the FBuddy screen. As simple as that!

Mobile Friendly Look

You don't need to be in front of a computer to set up a test, or access your results. Add the TTS website to your Home Screen - this will place the TTS logo on your device for quick access to our services and your Dashboard.

Easy Navigation

Based on your feedback we have placed strategic buttons throughout the site to take you to the most used sections/actions on the site. On mobile devices you will find a "hamburger" button on the top right section with provides quick access to all of our sections and pages.


About Talent Testing Services, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA and Las Vegas, NV.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service, Inc. (TTS) is happy to announce that it has reached an agreement with Clinique Médicale Millénia
in Montreal to become the first Associated Drawing Facility (ADF) in Canada. The clinic will collect and ship samples from their site to our headquarters in Miami as any other ADF in the United States.

"We have received requests from Producers/Agents/Talents to open an ADF in Canada. After talking to various clinics in the area, we are excited to have Clinique Médicale Millénia in Montreal as part of our ADF network. Like in the United States, a customer can log into our website, pay for the testing and show up at Clinique Médicale Millénia for testing." said Sixto Pacheco, President & CEO of TTS.

Site Location:

Clinique Médicale Millénia
150 Rue Sainte Catherine Ouest
Montreal, Quebec H5B 1B2
Canada

Hours of operation:

Monday - Friday: 7:30AM - 3:30PM

Results Availability:

- Collections Monday through Thursday: Next day around 6:00pm EST
- Collections on Friday: Next Monday around 6:00pm EST
- Expedited services are available

About Talent Testing Services, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and subsidiary offices in Los Angeles, CA and Las Vegas, NV.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Yesterday, an alert Producer in the Los Angeles area spotted a fake Talent Testing Service Inc. (TTS) paper result. According to Sixto Pacheco, President of TTS, this is the second time this year that someone tries to con the industry with a fake Talent Testing result. In both instances the person was caught and banned from the TTS testing system.

TTS would like to remind Talents, Agents and Producers that we have two key validation features in printed and web based Talent test result. that everyone can use:

QR CODES: Implemented on December 2011

We implemented QR Code Technology to protect the validity of all printed and web based results. All results now have a QRCode 2 Square below the results section of the report that when used in conjunction with any smart phone QR Code scanning software (such as ScanLife by Scanbuy, Inc. or Scan by QR Code City, LLC) it will show if the results are authentic and valid.

Once the barcode has been scanned, the browser will direct you to the TTS Mobile page that shows the Talent Id#, Date of Birth (DOB), Test Expiration Date (based on a 30-day testing cycle), and the actual test results. This technology will permit any user viewing an actual paper result to verify its authenticity on-demand.

AUTHENTICATION CODES:

If you don't have access to software to read the QR Code, we provide an Authentication Code in each test performed. The Authentication Code for each test is found on the far right of each test result.

To use the code, simply visit www.talenttestingservice.com, where you will find a big tab labeled Test Authentication. Clicking on it will show you a new page where you enter the authentication code and a security code and results will be displayed and validated.

TTS has always been ahead of the curve in implementing leading edge technology and innovation. In addition to the QR Code and mobile access features, Producers/Agents as well as Talents are provided with a personal online dashboard with access to historical and most up-to-date testing information. Talents can also set up automatic reminders for next test dates.

About Talent Testing Services, Inc. (TTS)

Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable and convenient talent testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida with subsidiaries in Las Vegas, Nevada and Los Angeles, California.

https://www.talenttestingservice.com

info@talenttestingservice.com

Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812 / Las Vegas (702) 868 8900

Twitter @talenttesting

Talent Testing Service, Inc. (TTS) is happy to announce that it has reached an agreement with the Huntridge Family Clinic in Las Vegas, NV for the collection and shipping of samples at no additional cost to talents.

"We are fortunate to have the Huntridge Family Clinic as one of our premier ADF (Associated Drawing Facilities). Talent will sign up online and neither shipping nor draw fees will be assessed" said Sixto Pacheco, President & CEO of TTS. "In addition to this, talents will also benefit by receiving their results by 10:30AM Pacific Time / 01:30PM Eastern Time. This is due to the fact that all samples collected at this facility, as with our Northridge facility, will be sent using the "Next Day Early AM" service offered by UPS." Pacheco continued.

Site Location:

Huntridge Family Clinic
2100 S. Maryland Parkway
Suite 1
Las Vegas, NV 89104

The hours of operation at the site are:

Mondays & Thursdays: 10:00AM - 1:30PM
Tuesdays, Wednesday and Fridays: 10:00AM - 5:00PM
Saturdays: 10:00AM - 2:00PM

About Talent Testing Services, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

"We welcome Bobby and Jen to the TTS group. Their integration into TTS, and their experience in the industry, will add a more transparent and unified testing service to the industry." said Sixto Pacheco, President & CEO of TTS. "Taking our services to the next level by improving accessibility to new and novel testing methodologies, as well as providing the "best of breed customer service" are things that drive TTS. I am sure Bobby and Jen will further our mission to accomplish these goals." Pacheco continued.

About Talent Testing Services, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service, Inc. (TTS) has added additional delivery options to its nationwide customer base to include a "Next Business Day Expedited" and "Saturday" overnight delivery. These additional services to the delivery platform at TTS will make turnaround times even faster.

"Adding these delivery service functionalities to our TTS online ordering system further enhances the delivery options on how samples are delivered based n the talents needs and schedule." said Sixto Pacheco, President & CEO of TTS. "By adding these services, talents will be able to take advantage of "Next Business Day Expedited" which will deliver samples on time for the morning run and have results available by 01:30PM EST. The "Saturday Delivery" option will allow talents to get their blood drawn on Friday and not have to wait until the following Monday to receive the results as these will be ready by 06:00PM EST that Saturday." Pacheco continued.

Enhanced Results Schedule Availability

• Next Business Day: The samples arrive mid morning the next business day and your results are ready by 06:00PM EST / 03:00PM PST.

• Next Business Day Expedited: This option will have samples arriving at our lab by 08:00AM EST and your results are ready by 01:30PM EST / 10:30AM PST.

• Saturday Delivery: This option is available for Talents who visit our draw sites on Friday. This option will have your samples arrive on Saturday and your results ready by 06:00PM EST / 03:00PM PST that same Saturday.

About Talent Testing Services, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

April 2nd, 2014

Talent Testing Service, Inc. (TTS) will be conducting the first in a series of informative webinars. The first of its kind in the adult industry, these webinars further enhance the visibility between TTS operations and its stakeholders.

"As part of our ongoing commitment to transparency with our stakeholders, we have started a series of webinars with specific topics that will be of interest to the adult community as a whole." said Sixto Pacheco, President & CEO of TTS. "These webinars will provide an insight on operational activities that affect producers, agents and talent alike." Pacheco continued.

Webinar #1:

Interpreting TTS Reports and Learning the Telltale Signs of a Falsified Report
Date & Time: Monday, April 14th - 03:00PM PDT (12:00PM EST)

This first 30-minute webinar will concentrate on interpreting results reports and how to ensure reports have not been altered. Some of the items to be covered will include QR Codes, Embedded Talent Pictures, Generation Logs and Authentication Codes.

Registration

Anybody interested in participating in the webinar can register by April 11th 2014 at:

https://attendee.gotowebinar.com/register/2107161615546444289

About Talent Testing Services, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service, Inc. (TTS) has launched live beta testing of its TTS HealthWatch (TTShw) program.

At a Glance

TTS HealthWatch (TTShw), is a database of events with performers compiled by producers, agents and talents themselves indicating who performed with whom. By entering this information in the database, a generational testing tree can be produced within seconds thus permitting a rapid response during an industry moratorium when callbacks are initiated. The system is open to current participating and non-participating TTS customers….the system is for the benefit of all industry stakeholders.

Triple Tier Check System

TTShw has been built to have a system of checks and balances. Production information received from producers, agents and talents will permit the generational tree created to be more robust avoiding any splintering in the identification and testing of possible infected cases.

Beta Testing Sites and Implementation Process

Currently TTShw is being tested at select production companies. Once this initial testing is completed and feedback has been obtained and implemented, the process will then move on to agents and talents. Obtaining feedback from these three stakeholders during this process is as important as the system itself. It is expected that by the end of the first quarter of 2014, the system will be up and operational at a national level. Additional production companies that would also like to participate in the beta testing phase should contact TTS via info@talenttestingservice.com.

"2013 was the year of moratoriums for the adult industry." said Sixto Pacheco, President & CEO of TTS. "We believe that the industry as a whole can manage these shutdowns swiftly and efficiently with the use of the TTShw program. At this time we have begun beta testing at select Production Companies obtaining initial feedback in order to enhance its features before implementing it at a national level." Pacheco continued.

About Talent Testing Services, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

GSP Testing Panel

On September 1st, 2013 Talent Testing Service, Inc. (TTS) will be introduce a new comprehensive testing protocol called the "Gold Standard Panel" (GSP). This GSP will replace both the Basic and Full Panels currently offered by consolidating the latest testing methodologies into one comprehensive product and furthermore strengthen Primary and Secondary testing algorithms for the detection of STD's in the adult industry.

The GSP will be comprised of the following EIGHT tests:

1. HIV-1 NAT
2. HBsAg
3. Anti-HCV
4. Chlamydia
5. Gonorrhea
6. Trichomonas Vaginalis AND
7. Two Syphilis tests:
o RPR
o TREP-SURE EIA - Treponema pallidum Antibody, IgG by ELISA

Please note that all molecular tests are performed based on single test / single talent testing protocols. Pooling of material is not a standard practice at TTS.

Improved Test Results Delivery Times

TTS will also be providing its clients test results TWICE a day: at 1:00pm EST/10:00am PST and 6:00pm EST/3:00pm PST, Monday through Friday. If you test at our LA office on Monday by 5:00pm PST, your results will be ready by 10:00am PST the next day.

"These changes come after consultations with Talents, Agents and Production companies throughout the industry." said Sixto Pacheco, President & CEO of TTS. "TTS prides itself at being at the forefront of industry leading testing protocols. The GSP and additional results availability times are in line with our commitment to continuously improve the available safeguards directed at the health of the Talent and the industry as a whole" Pacheco continued.

Clearance Issues on FSC/APHSS/PASS System

TTS believes there is a testing loophole in the FSC/APHSS/PASS Clearance database. "As we have previously stated to FSC/APHSS/PASS, we have strongly recommended that the facility issuing a Non-Clearance to a talent into system must also be responsible for issuing the follow up clearance." Pacheco said. "At this time, some talents that are not cleared by TTS, due to more rigorous testing protocols in place, shop around for a less stringent panel in order to obtain a follow-up clearance." Pacheco continued. "This simple change in policy will have an enormous positive impact on the clearance system".

About Talent Testing Services, Inc. (TTS)

As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

"We are very happy to welcome CET in their decision to offer free HBsAg and anti-HCV as part of their basic panel." said Sixto Pacheco, President & CEO of TTS. "As a further insight to this program, we encourage CET and all other APHSS participating facilities to only use FDA cleared Whole Blood Donor grade reagents for this type of screening. This is very important in assuring that all talent tests provide the same baseline in clearing talent and resetting the health statistics." Pacheco continued.

As part of the TTS Health Awareness Month, the industry's leading Basic Panel Test offers the most complete testing panel available for Talents, in over 300 locations, with a 24-hour turnaround. The panel includes:

•HIV-1 NAT
•Chlamydia
•Gonorrhea
•Syphilis (RPR) plus the TREP-SURE EIA - Treponema pallidum Antibody, IgG by ELISA
•HBsAg
•Anti-HCV

About Talent Testing Services, Inc. (TTS)
As the leader in setting testing standards for the industry, Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

With the safeguard of the Talents and the Industry in mind, Talent Testing Service, Inc. (TTS) will start screening for Hepatitis B (HBV) and Hepatitis C (HCV) on ALL Basic Panel Tests effective June 7th, 2013. The Full Panel Test price will change to $120.00 and applies for all samples collected at our Talent Testing facilities in Northridge, CA, Miami, FL and all of our 300 Draw Stations around the country. The Health Screening will end on July 7th, 2013.

"Today we are implementing what we call TTS Industry Screening Month." said Sixto Pacheco, President & CEO of TTS. "We hope that everyone, from established Talents to new comers to the industry, take advantage of this additional screening at no extra cost. This month long event will also reset the industry health statistics giving us a clean slate for the second half of the year." Pacheco continued.

According to the CDC and American Cancer Society, viral hepatitis is a leading infectious cause of death in the U.S. The majority of liver cancers in the world are attributable to chronic infections of HBV and/or HCV. Primary prevention of HBV infection includes vaccination. HCV infection is potentially preventable through public health measures, including screenings.

As with the addition of Syphilis testing on the Basic Panel test, the Health Screening initiative supports TTS's ongoing commitment to offer the most advanced and complete infectious testing for the adult industry.

About Talent Testing Services, Inc. (TTS)

Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Services, Inc. (TTS) announced today that its current testing methodologies for Gonorrhea (GC) detect the new strain referenced to as "H041".

"Our testing methodologies in place have been developed and cleared to detect these emerging strains." said Sixto Pacheco, President & CEO of TTS. "The APTIMA Combo 2 assay for GC and CT targets the ribosomal RNA (rRNA). Antibiotic resistance in GC occurs due to mutations in genes other than those that express rRNA. Because we target the rRNA for detection of GC, which is not affected by the mutations, the APTIMA Combo 2 assay will detect the drug resistant strains of GC." Pacheco continued.

TTS is at the forefront of testing methodologies due to its strategic partnerships with diagnostic manufacturers. These partnerships permit TTS to work proactively to introduce and maintain the most advanced testing methodologies and provide these to the adult industry.

The forward thinking company has long offered testing for HIV RNA by PCR Methodology, which detects the presence of the virus earlier than all other tests. Testing for Hepatitis B, Hepatitis C, Gonorrhea, Chlamydia, Syphilis and others is also available.

About Talent Testing Services, Inc. (TTS)
Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Services, Inc. (TTS) announced today that its testing policy for syphilis, under its current basic panel, will continue to include the TrepSure™ EIA test. This test will be used in conjunction with RPR and will continue to be an integral part of its basic clinical panel including the molecular tests for HIV, Chlamydia and Gonorrhea.

"The TrepSure™ EIA test offers an additional protection of our talent population as an initial indicator for syphilis. Used in conjunction with the RPR test plus patient history, TrepSure™ indicates past infections and is an effective indicator of acute syphilis infection." said Sixto Pacheco, President & CEO of TTS. "Talent Testing Service will continue to develop comprehensive test programs that not only protect the health of the talent but also address our industry's concerns." Pacheco continued.

TTS will continue to provide cleared status information to the APHSS database based on the existing clearance algorithm currently in place.

The forward thinking company has long offered testing for HIV RNA by PCR Methodology, which detects the presence of the virus earlier than all other tests. Testing for Hepatitis B, Hepatitis C, Gonorrhea, Chlamydia, Syphilis and others is also available.

About Talent Testing Services, Inc. (TTS)
Talent Testing Service, Inc. (TTS) consistently offers talents safe, courteous, affordable and convenient testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Miami, FL August 31, 2012 - Talent Testing Services, Inc. (TTS) has been monitoring the developments regarding the recent Syphilis outbreak in the industry. As part of our ongoing approach to offer the best and most sensitive assays in the industry, our policy has always been to provide "Whole Blood Donor" grade approved screening assays and testing algorithms. These assays and testing algorithms are the once used to protect our Nation's blood supply.

The RPR test is the standard in the industry to detect Syphilis. As part of the testing algorithm, if a reactive result arises, a follow-up confirmatory treponema test is performed in order to confirm the result. It is also recommended that if a case arises where recent exposure with a carrier has been identified (first generation), the RPR in conjunction with the confirmatory treponema test and preemptive treatment should be the prudent course of action. This Syphilis screening algorithm is what is recommended by the Center for Disease Control (CDC).

The health and well being of the Talent, as well as the continued success of the Adult industry will always be at the forefront of what we provide.

About Talent Testing Service, Inc. (TTS)
Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable, and convenient talent testing through wholly owned subsidiaries or collaborating sites. Since 2006, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Miami, FL August 28, 2012 - Talent Testing Services, Inc. (TTS) in response to the recent syphilis outbreak, the growing industry concern over STDs, and the misinformation that has come along with it, TTS has named Dr. David Smith, M.D., M.A.S., an infectious disease specialist, to head its Internal Medical Council and Outreach Program. Dr. Smith's qualifications make him the top candidate to head this initiative of Talent Testing Service, Inc.

The TTS Medical Council and Outreach Program will help answer questions from Talents, Agents and Production companies regarding syphilis treatment, HIV, HBV, HCV and any others related to sexually transmitted diseases. "Given the recent syphilis outbreak we have seen a lot of misinformation being exchanged back and forth in the industry. This helps no one." said Sixto Pacheco, President of TTS. "The TTS Medical Council and Outreach Program, now headed by Dr. Smith, will have as its prime directive to educate, inform and proactively address the health issues of the Talent community and industry," continued Mr. Pacheco.

Talents, Agents and Production companies can email questions, in full confidentiality to questions@talenttestingservice.com and these will be answered in a timely manner. Production companies and Agents interested in scheduling a conference call with Dr. Smith, can contact Richard Reiss at rreissm@talenttestingservice.com for additional information and scheduling times.

Talent Testing Service, Inc. will continue to innovate and implement leading edge technologies and testing methods to safeguard the health of Talents and the industry.

About Talent Testing Services, Inc. (TTS)

Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable and convenient talent testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792-2090 / Los Angeles (818) 885-0812

Twitter: @talenttesting
Facebook: facebook/talenttesttingservice

Miami, FL August 23, 2012 - Talent Testing Services, Inc. (TTS) categorically denies that there has been any inappropriate behavior on the part of its personnel to accommodate Mr. Marcus's request to alter the Basic Talent Panel test results. Our proprietary software has different levels of security embedded into its code to protect the integrity of the test result report. If a Talent chooses a Basic Talent Panel, or a Full Talent Panel, ALL test in the panel selected have to be performed before the system provides a "Cleared" or "Not Cleared" status.

If the Talent is reactive/positive to any of the markers in the panel, the system will automatically disable the results and provide a "Not Cleared" status. This means that the results can not be either emailed, printed or shown on the screen.

With regards to the manipulation of the printed test results, TTS since 2011, has included QR Codes and Authentication Codes, in its printed results, to avoid anyone fabricating a report. The only flaw in the system is that it has to be used for it to work.

Since 2007 Talent Testing Services has been ahead of the curve implementing leading edge technologies and testing methods to safeguard the health of Talents and the industry. We look forward to the industry's continued support.

About Talent Testing Services, Inc. (TTS)
Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable and convenient talent testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter @talenttesting

Miami, FL August 21, 2012 - Talent Testing Services, Inc. (TTS) would like to remind Talents, Agents and Producers the many validation features found in a printed and web based Talent test result.

QR CODES: Implemented on December 2011
We implemented QR Code Technology to protect the validity of all printed and web based results. All results now have a QRCode 2 Square below the results section of the report that when used in conjunction with any smart phone QR Code scanning software (such as ScanLife by Scanbuy, Inc. or Scan by QR Code City, LLC) it will show if the results are authentic and valid.

Once the barcode has been scanned, the browser will direct you to the TTS Mobile page that shows the Talent Id#, Date of Birth (DOB), Test Expiration Date (based on a 30-day testing cycle), and the actual test results. This technology will permit any user viewing an actual paper result to verify its authenticity on-demand.

AUTHENTICATION CODES:
If you don't have access to software to read the QR Code, we provide an Authentication Code in each test performed. The Authentication Code for each test is found on the far right of each test result.

To use the code, simply visit www.talenttestingservice.com, where you will find a big tab labeled Test Authentication. Clicking on it will show you a new page where you enter the authentication code and a security code and results will be displayed and validated.

We are making the following enhancements to the results format:

1. The results will display, bellow the performers Date of Birth, what type of test the Talent selected. This could be either BASIC TALENT PANEL or FULL TALENT PANEL.

2. If, for any reason, one of the test appears positive/reactive, the 7/14/30 Day Expiration Section of the results will display "NOT CLEARED".

TTS has always been ahead of the curve in implementing leading edge technology and innovation. In addition to the QR Code and mobile access features, Producers/Agents as well as Talents are provided with a personal online dashboard with access to historical and most up-to-date testing information. Talents can also set up automatic reminders for next test dates.

About Talent Testing Services, Inc. (TTS)
Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable and convenient talent testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter @talenttesting

August, 9, 2012 - Miami, FL - Talent Testing Service, Inc. (TTS) announces a partnership program with the University of California, Los Angeles for a sexual health study. Conducted by UCLA researchers, the study is designed to examine the presence of Gonorrhea and Chlamydia in urine, rectal and throat test samples. Any current or new TTS clients may opt in to receive the free additional testing and will be compensated $40.00 for participation and $10 for each additional person that participates via their referral. All testing is completely confidential.

Interested clients will be processed as follows:

1. Go to the Northridge, California office.
2. Opt in to participate in the study.
3. Read and sign an Informed Consent Form (ICF).
4. Samples will be collected.
5. Complete a brief electronic questionnaire on a tablet (i.e. i-Pad)
6. Receive a US $40.00 gift card.

Participants who test positive for Gonorrhea or Chlamydia will be provided with treatment supervised by a physician at no cost.

This partnership supports TTS's ongoing commitment to the most advanced infectious molecular testing for the adult industry. Since 2006, TTS has offered testing for HIV RNA via the FDA approved PCR test that detects the presence of the HIV virus earlier than all other tests. The company offers affordable testing options including a Basic Panel (HIV, Chlamydia, and Gonorrhea) for $110, and a Full Panel (HIV, Chlamydia, Gonorrhea, and Syphilis, Hepatitis B, Hepatitis C) for $150.

Talent Testing Service, Inc. caters to their clients by providing the most up-to-date technology. The company uses QR Codes for validating printed test results, as well as a convenient mobile page for verification of authenticity on-demand and access to actual test results. Producers/Agents as well as Talents are provided with a personal online dashboard that provides access to historical and most recent testing information. Furthermore, Talents can set up automatic reminders for next test dates.

About Talent Testing Service, Inc. (TTS)
Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable, and convenient talent testing through wholly owned subsidiaries or collaborating sites. Since 2006, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service, Inc. (TTS) worked diligently to comply with three basic requirements in order to appease the Manwin/FSC/APHSS model of presenting a unified reporting system. These three items were:

1. Change our web portal to demonstrate a "Cleared/Not Cleared" status of results instead of showing the actual test results.
2. Automated transfer of Talent Status to the APHSS Database
3. Cooperate in helping to build protocols in case of a positive case.

Once these three items were completed, Manwin/FSC/APHSS was to issue a press release indicating that it would accept TTS test status to be viewed in the TTS web portal by its producers and agents. After completing the first two items, TTS was asked to provide its protocols for handling positive cases to Manwin/FSC/APHSS. We indicated that this was not part of our agreement, that we would assist and help to create these needed protocols (as agreed), but we would not have ours copied for use at Manwin/FSC/APHSS. We consider these protocols to be proprietary and confidential. At this time Manwin/FSC/APHSS demanded to see these procedures for which we declined.

"It has become evident that our initial position of not participating in the Manwin/FSC/APHSS mechanism for testing / reporting is the correct one." said Sixto Pacheco, President and CEO of TTS. "We have always believed that industry testing laboratories should be completely unbiased and unattached from any other industry affiliated organizations in order to avoid any misconception about the validity of the testing being performed. Furthermore, the manual entry of a talents "Status" into the Manwin/FSC/APHSS database by any participating facility is an unsafe practice." added Mr. Pacheco.

TTS will continue to provide the level of service our stakeholders are accustomed to by providing the latest testing methodologies coupled with our technology based platform without sacrificing our Quality and Privacy Policies and Protocols in place.

Talent Testing Services, Inc. caters to their clients by providing the most up-to-date technology. The company uses QR Codes for validating printed test results, as well as a convenient mobile page for verification of authenticity on-demand and access to actual test results. Producers/Agents as well as Talents are provided with a personal online dashboard that provides access to historical and most recent testing information. Furthermore, Talents can set up automatic reminders for next test dates.

About Talent Testing Services, Inc. (TTS)
Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable, and convenient talent testing through wholly owned subsidiaries or collaborating sites. Since 2006, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service, Inc. (TTS) is announcing a new After Hours phone number for any related Talent Testing Service question. The new phone number is (909) 553-7704.

"We want to be accessible for all our Talents and Agents/Producers, no matter what time of day. If they have an urgent request outside of normal business hours, they can call us at (909) 553-7704, and someone in our LA office will be able to help them," said Sixto Pacheco, President Talent Testing Service.

TTS believes the new After Hours number, complements the DM's (Direct Messages) we have been handling on Twitter through our handle @talenttesting.

About Talent Testing Services, Inc. (TTS)
Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable, and convenient talent testing through wholly owned subsidiaries or collaborating sites. TTS is a CLIA Certified and COLA Accredited testing facility holding licenses in several states including Florida and California. TTS is a privately held company with headquarters in Miami, Florida and has a subsidiary office in Los Angeles, CA.


https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
After Hours (909) 553-7704
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Talent Testing Service, Inc. (TTS) welcomes the move by Manwin and APHSS in adopting new testing standards that require their performers and third party producers visit clinics/laboratories that only use the FDA approved HIV-1 Aptima RNA Qualitative Assay.

"Talent Testing Service has been offering the HIV-1 Aptima RNA Qualitative Assay approved since 2006 as part of our company philosophy to provide the most accurate and reliable testing to the industry." said Sixto Pacheco, President and CEO of TTS. "The implementation of this methodology by TTS was a welcomed addition to our product offering which continues to evolve as new technologies emerge" added Mr. Pacheco.

Earlier this month TTS decided that it would integrate as part of its Basic Panel the RPR test which is used to test for syphilis. The addition of this test did not affect the cost structure being offered to the talents.

To facilitate our clients the accessibility to its testing program, TTS has over 300 drawing sites across the United States staffed with courteous licensed professionals, offering Talents unparalleled convenience, safety and service. We provide same day test results for clients who visit our Miami office before 12pm, and 24 hour test results for clients who visit the other 300 facilities.

Talent Testing Service, Inc. (TTS) also caters to their clients by providing the most up-to-date technology. The company uses QR Codes for validating printed test results, as well as a convenient mobile page for verification of authenticity on-demand and access to actual test results. Producers/Agents as well as Talents are provided with a personal online dashboard that provides access to historical and most recent testing information at no cost. Furthermore, Talents can set up automatic reminders for next test dates.

About Talent Testing Services, Inc. (TTS)
Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable, and convenient talent testing through wholly owned subsidiaries or collaborating sites. TTS is a CLIA Certified and COLA Accredited testing facility holding licenses in several states including Florida and California. TTS is a privately held company with headquarters in Miami, Florida and has a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

In its effort to provide the most comprehensive and accurate testing in the Adult Industry, Talent Testing
Service, Inc. (TTS) will now offer Syphilis testing as part of the TTS Basic Panel option. The Syphilis
test will complement the HIV-1 RNA and Chlamydia / Gonorrhea testing already offered in the TTS Basic
Panel. The cost of the TTS Basic Panel will remain the same.

The methodology used will be the RPR (rapid plasma regain) screening test for Syphilis. This test
looks for antibodies that are present in the blood of people who have the disease. Syphilis is a sexually
transmitted infection (STI) that is usually spread during sexual contact, including kissing and/or oral sex.
This test is approved by the FDA and is currently used to screen the US Blood Supply.

The addition of this test supports TTS's ongoing commitment to offer the most advanced and complete
infectious testing for the adult industry. Since 2006, TTS has offered testing for HIV RNA via the FDA
approved Aptima PCR Methodology which detects the presence of the HIV virus earlier than all other
tests.

Talent Testing Service, Inc. (TTS) caters to their clients by providing the most up-to-date technology.
The company uses QR Codes for validating printed test results, as well as a convenient mobile page
for verification of authenticity on-demand and access to actual test results. Producers/Agents as well as
Talents are provided with a personal online dashboard that provides access to historical and most recent
testing information. Furthermore, Talents can set up automatic reminders for next test dates.

About Talent Testing Services, Inc. (TTS)

Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable, and convenient talent testing
through wholly owned subsidiaries or collaborating sites. Since 2006, TTS has provided the most
advanced infectious molecular testing for the adult industry. TTS is a privately held company with
headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles, CA (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

HIV-1 RNA Testing - Miami, FL - April 9, 2012

Determining the best HIV testing methodology is a critically important issue especially for our industry. For the past 12 years, Talent Testing Service, Inc. (TTS) has been at the forefront of this discussion. We have researched technological advancements, reviewed the opinions of policy makers and stakeholders and kept up-to-date on FDA discussions regarding testing methods.

We have been directly involved in the research development of these new and emerging infectious disease testing methodologies. This research strives to help develop the most sensitive assays in order to detect the HIV virus (amongst other infectious markers) at its' most primal state. Our laboratory is a high complexity molecular laboratory holding a federal CLIA Certificate as well as being COLA accredited.

TTS' test methodology for HIV-1 RNA is marketed under the name "Aptima HIV-1 RNA Qualitative Assay". This FDA Approved assay is intended for the detection of HIV-1 in human plasma and serum as a diagnostic tool in detecting HIV-1 infection, including acute or primary infection. Although not stated in its trademarked name, this qualitative assay employs reverse transcriptase (RT) when transforming RNA to DNA and then back to RNA (Please see attached APTIMA HIV-1 RNA Qualitatitve Assay Insert - Principles of the Procedure).

Another well known assay in the market is the "Abbott RealTime HIV-1" assay. This is another reverse-transcription (RT) assay intended for the Quantification of the HIV-1 virus in previously identified HIV-1 infected individuals. It is intended for use in conjunction with clinical presentations and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to anti-retroviral treatment as measured by changes in plasma HIV-1 RNA levels (See Attached insert). This test is very useful in already HIV-1 diagnosed individuals as a treatment tool for physicians. However, TTS' concerned with this methodology is that it is a Quantitative tool and is less sensitive at detecting HIV-1 RNA than the Qualitative APTIMA assay. Consequently, if the Abbott RT HIV-1 assay is used as a screening assay to detect HIV-1, this use is considered an "off label use" as it has not been approved by the FDA to be used for this purpose. There are many other assays that are considered to be "home brew" or "in-house" assays. These assays are also referred to as LDA's (Laboratory Developed Assays). Although these alternatives may meet our testing needs, they have not gone through the extremely rigorous scrutiny required to meet the quality standards of the FDA.

TTS currently holds the technology to perform both assays mentioned above and employs the APTIMA technology for diagnosing HIV and the Abbott m2000sp/rt for patient management. It is our understanding that the use of a Qualitative FDA approved methodology is more sensitive than a Quanitative assay since their intended use is different. Another determining factor for the use of the APTIMA HIV-1 technology is that it is the market leading assay employed in the screening and safeguarding of the nation's blood supply.

TTS has always had an open door policy with its stakeholders - our talents, agents, producers, regulatory officials and others involved in the industry. As such, we invite anyone to come to our testing facility and tour the same. In addition to this, TTS will always strive to continue its R&D efforts to protect the industry in regards to its diagnostics needs. Notwithstanding, if a governing body or any stakeholder requests that a different technology be employed to protect our industry we will look forward to evaluating those options.

TTS is proud to be working with all of you on these issues. Through time and conversation, we will continue to be successful in meeting our interest and the interests of all of our stakeholders.

About Talent Testing Services, Inc. (TTS)

Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable, and convenient talent testing through wholly owned subsidiaries or collaborating sites. Since 2006, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter: @talenttesting
Facebook: facebook.com/talenttestingservice

Miami, FL March 12, 2012

Talent Testing Services, Inc. (TTS) now offers QR Code Technology for validating printed test results. The QR Code scan directs clients to the TTS Mobile page for convenient verification of authenticity on-demand as well as access to actual test results.

TTS has always been ahead of the curve in implementing leading edge technology and innovation. In addition to the QR Code and mobile access features, Producers/Agents as well as Talents are provided with a personal online dashboard with access to historical and most up-to-date testing information. Talents can also set up automatic reminders for next test dates.

Since 2006, the forward thinking company has offered advanced testing for HIV RNA via the FDA approved PCR Methodology. This testing method detects the presence of the HIV virus earlier than all other tests.

Talent Testing Services offers safe, reliable and affordable testing with quick turnaround times. The Basic Panel (HIV, Chlamydia, and Gonorrhea) costs just $110. A Full Panel (HIV, Chlamydia, Gonorrhea, and Syphilis, Hepatitis B, Hepatitis C) is available for $150.

With over 300 drawing sites across the US staffed with courteous professionals, TTS also offers Talents unparalleled convenience, safety and service.

About Talent Testing Services, Inc. (TTS)
Talent Testing Service, Inc. (TTS) provides safe, courteous, affordable and convenient talent testing through wholly owned subsidiaries or collaborating sites. Since 2007, TTS has provided the most advanced infectious molecular testing for the adult industry. TTS is a privately held company with headquarters in Miami, Florida and a subsidiary office in Los Angeles, CA.

https://www.talenttestingservice.com
info@talenttestingservice.com
Miami, FL (Headquarters) (305) 792 2090 / Los Angeles (818) 885 0812
Twitter @talenttesting

@TalentTesting has announced its 2011-2012 holiday schedule. Please vew our holiday testing schedule at:

https://www.talenttestingservice.com/attachments/ttsmsg/2011-12%20-%20December%20-%20January%20TTS%20Holiday%20Testing%20Schedule.pdf (Please click on this link or copy and paste the same onto your browser address bar).

For any additional questions, please feel free to contact us at info@talenttestingservice.com.

Talent Testing Services, Inc. (TTS) has announced today that it has implemented QR Code Technology to protect the validity of all printed results. All printed results now have a QRCode 2 Square at the bottom of each page that when used in conjunction with any smart phone QR Code scanning software (such as ScanLife by Scanbuy, Inc. or Scan by QR Code City, LLC) will show if the results are authentic and valid.

Once the barcode has been scanned, the browser will direct you to the TTS Mobile page that shows the Talent Id#, Date of Birth (DOB), Test Expiration Date (based on a 30-day testing cycle), and the actual test results. This technology will permit any user viewing an actual paper result to verify its authenticity on-demand.

For any questions regarding the use of this technology, please contact TTS at info@talenttestingservice.com.

We are delighted to announce the launch of our mobile website: www.talenttestingservice.com. Now your test results and some basic features of the dashboards are available for you to use on the go, no matter where you are.

Like many mobile sites, our mobile website is a pared down version of the full site for ease of navigation and speed of download onto your mobile device. We have kept the best features of our main website including access to your personalized dashboard and affiliated draw location search.

Features:

- Talents: Access your test results, E-Mail test results feature.
- Producers/Agents: Pre Authorized Search of talent results.
- Find Affiliate Draw Locations Near You.
- Contact us features.

Mobile devices supported:

The mobile site is targeted at devices with smaller screens such as smart phones, and should work with most devices that have a browser installed. Usability enhancements have been applied for the most popular mobile devices.

How to access the site:

- Direct www.talenttestingservice.com.
- Via the main site www.talenttestingservice.com via any mobile device.

Updates:

Please be on the lookout for future versions encompassing more features and benefits for our main website! We welcome any and all suggestions in order to improve the same. If you have an enhancement that you would like to share or encounter a bug, please feel free to let us know at info@talenttestingservice.com.

Please note that due to the Labor Day Holiday, no collections will be made on Friday September 2nd through Monday September 5th at TTS Drawing Stations. Our offices in Miami and Los Angeles will be open on Friday September 2nd, but will be closed on Saturday September 3rd and Monday September 5th. We will resume normal operations on Tuesday, September 6th.

ANY LAB TEST NOW has been named as a new collection partner for Talent Testing Service. The facilities will collect urine and blood samples which will then be tested by Talent Testing Service. This proactive health and safety measure is designed to help provide a safe work environment for adult entertainers. "We are pleased to be a part of the Talent Testing Service collection network and our highly trained staff is looking forward to servicing the Talent Testing Service clients in a professional manner," stated Clarissa Bradstock, COO, ANY LAB TEST NOW.

ANY LAB TEST NOW has over 130 locations nationwide. Clients can be assured of privacy and confidentiality and each ANY LAB TEST NOW location is convenient to public transportation with retail hours that don't interfere with responsibilities or employment. With no appointment necessary and no waiting, ANY LAB TEST NOW makes specimen collection simple and easy. Samples are collected by supportive and certified specimen collectors.

Due to the increased volume of talents being tested we have been able to increase the number of runs performed each week resulting in quicker turn-around times. In addition, we have also included same-day turn around for talents drawn at our Miami office before 10:00AM. Please see our results availability schedule for further details.

We open our account on twitter, @TalentTesting for updates on new drawing sites, testing results availability and other events!